{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Yojana Gadiya",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/4aa36980578c7d2cff07371abf768f15db89cd11/export/conso-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/0816cb6686751420365441adc6a28ced2d272f14/external/mesh-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/ncbigene.belns"
    },
    "path": "ms/correale2017.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Multiple sclerosis is a chronic inflammatory disease of the CNS leading to demyelination and neurodegeneration.",
      "key": "d99c8bdc6fcd70b76e3f261c4ed06520",
      "line": 79,
      "relation": "isA",
      "source": 152,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Multiple sclerosis is a chronic inflammatory disease of the CNS leading to demyelination and neurodegeneration.",
      "key": "c9c9e44d463d16e5a6e3824092f7950f",
      "line": 80,
      "relation": "increases",
      "source": 152,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Multiple sclerosis is a chronic inflammatory disease of the CNS leading to demyelination and neurodegeneration.",
      "key": "415ac1cf461802d40ca96ce712a10a4f",
      "line": 81,
      "relation": "increases",
      "source": 152,
      "target": 157
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Results from immunological, genetic and histopathology studies of patients with multiple sclerosis support the concept that autoimmunity plays a major role in disease pathogenesis (McFarland and Martin, 2007)",
      "key": "4c710d3ae957e294d2ff136b3af1af81",
      "line": 89,
      "relation": "association",
      "source": 152,
      "target": 166
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "The course of multiple sclerosis is highly variable; nevertheless in most patients, multiple sclerosis is characterized by the onset of recurring clinical symptoms followed by total or partial recovery, namely, the classic relapsingremitting form of multiple sclerosis (RRMS).",
      "key": "c5a53989950f229acf2a16ae8f6a331a",
      "line": 99,
      "relation": "increases",
      "source": 152,
      "target": 154
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Indeed, the most active cortical multiple sclerosis lesions are crowded with CD8 + T cells and contain few B cells or plasma cells, suggesting cortical inflammation might correlate with reduction in EBV-infected B/plasma cells numbers (Magliozzi et al., 2013).",
      "key": "e89ee0caa95387d5278e81a5741315c0",
      "line": 325,
      "relation": "increases",
      "source": 152,
      "target": 11
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Neuronal cell bodies in deeper layers of the cortex show evidence of impaired functional activity of mitochondrial respiratory chain complexes (Campbell et al., 2011), as well as alterations in motor proteins (encoded by nuclear DNA) responsible for the movement of the mitochondria from cell body to axons (Campbell et al., 2014).",
      "key": "15de10602428b643a6b65db0f2160497",
      "line": 583,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 152,
      "target": 117
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Neuronal cell bodies in deeper layers of the cortex show evidence of impaired functional activity of mitochondrial respiratory chain complexes (Campbell et al., 2011), as well as alterations in motor proteins (encoded by nuclear DNA) responsible for the movement of the mitochondria from cell body to axons (Campbell et al., 2014).",
      "key": "4a42909153b1415ce56c0bf87809656a",
      "line": 584,
      "relation": "decreases",
      "source": 152,
      "target": 121
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Global NAA measured across the whole brain is abnormally low in multiple sclerosis",
      "key": "411ecf95c757541d76b7168fafedd7d9",
      "line": 705,
      "relation": "directlyDecreases",
      "source": 152,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "LINGO1, a CNS-specific membrane glycoprotein that suppresses oligodendrocyte differentiation and myelination, is possibly involved in failure of remyelination and axonal repair in multiple sclerosis (Yong, 2009); blockade of this protein may therefore be effective in promoting remyelination in a clinical setting.",
      "key": "5108b2a24914fff1590e33d1876b17cb",
      "line": 889,
      "relation": "positiveCorrelation",
      "source": 152,
      "target": 106
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "5499678fe79f737b3b97652f270635f8",
      "line": 246,
      "relation": "positiveCorrelation",
      "source": 142,
      "target": 68
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "658d3a8b8aea7cd70ef45aec7a890bcb",
      "line": 247,
      "relation": "positiveCorrelation",
      "source": 142,
      "target": 162
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Active demyelination and neurodegeneration have also been linked to microglial activation in early lesions with accumulation of macrophages in injured tissues (Lassmann, 2014).",
      "key": "c31ac753afe6f771b73a2b1bda614ec3",
      "line": 393,
      "relation": "association",
      "source": 142,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Evidence from both imaging and pathology suggest that the inflammatory demyelinating process in early multiple sclerosis drives a pathogenic cascade of events causing neurodegeneration, which in turn is further amplified by brain ageing, microglial activation and accumulated disease burden (Popescu and Lucchinetti, 2012; Mahad et al., 2015).",
      "key": "0c424f2dca8b662ab428da7b77e4313f",
      "line": 530,
      "relation": "increases",
      "source": 142,
      "target": 157
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "addf66e45d7e62cff1d28705d9746e2b",
      "line": 241,
      "relation": "positiveCorrelation",
      "source": 157,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "2b2cd1cc1cc6b473f1ab6a5b2e5cda81",
      "line": 242,
      "relation": "positiveCorrelation",
      "source": 157,
      "target": 162
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Results from immunological, genetic and histopathology studies of patients with multiple sclerosis support the concept that autoimmunity plays a major role in disease pathogenesis (McFarland and Martin, 2007)",
      "key": "468c7418e8cc94a01134a98b86e1197c",
      "line": 89,
      "relation": "association",
      "source": 166,
      "target": 152
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Notably, follicle- like structures are probably able to sustain a high level of humoral response, as well as other autoimmune mechanisms within the CNS, in a manner independent of peripheral inflammation.",
      "key": "48489b6fe6d4c5e3f6635444b49bd8a5",
      "line": 233,
      "relation": "causesNoChange",
      "source": 166,
      "target": 162
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "One suggests that brain damage is driven by inflammatory processes similar to those observed during RRMS; but that during progressive disease stages, a microenvironment is created within the CNS favouring homing and retention of inflammatory cells, ultimately causing disease-modifying therapies to become largely ineffective (Frischer et al., 2009).",
      "key": "9c58222da86319acbdacd1d67eb5a112",
      "line": 105,
      "relation": "increases",
      "source": 154,
      "target": 68
    },
    {
      "annotations": {
        "Anatomy": {
          "spinal cord": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Although brain and spinal cord inflammation are present in RRMS, SPMS, and PPMS its extent declines with age and disease duration.",
      "key": "78e302ec8c189fcf52fcae5b79fa60d7",
      "line": 120,
      "relation": "increases",
      "source": 154,
      "target": 171
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "Cell": {
          "lymphocyte of B lineage": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "However, clonally-restricted B cells have been found in CSF from patients with RRMS (Kuenz et al., 2008) indicating intrathecal clonal expansion of B cells.",
      "key": "83aab4070983e4b75ecb5bb2c05cb607",
      "line": 220,
      "relation": "increases",
      "source": 154,
      "target": 133
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",
      "key": "56cb4e64ed2e49a602f08a36f577cedc",
      "line": 286,
      "relation": "causesNoChange",
      "source": 154,
      "target": 172
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",
      "key": "4fb52946ba03be9d66a05422c7c1b67c",
      "line": 290,
      "relation": "causesNoChange",
      "source": 154,
      "target": 174
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Whole brain MRS has successfully shown significant reduction in both NAA and NAA/creatine (NAA/Cr) ratio, in clinically isolated syndrome and RRMS, compared to healthy controls.",
      "key": "3acd3ce05c071cd8540506e9ec6363a4",
      "line": 717,
      "relation": "directlyDecreases",
      "source": 154,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "One suggests that brain damage is driven by inflammatory processes similar to those observed during RRMS; but that during progressive disease stages, a microenvironment is created within the CNS favouring homing and retention of inflammatory cells, ultimately causing disease-modifying therapies to become largely ineffective (Frischer et al., 2009).",
      "key": "a2cd7fca8b80af0bcb12c37af8d4b063",
      "line": 106,
      "relation": "negativeCorrelation",
      "source": 68,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "One suggests that brain damage is driven by inflammatory processes similar to those observed during RRMS; but that during progressive disease stages, a microenvironment is created within the CNS favouring homing and retention of inflammatory cells, ultimately causing disease-modifying therapies to become largely ineffective (Frischer et al., 2009).",
      "key": "55b69d21300a4cac7cf438dea917c2c4",
      "line": 107,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "One suggests that brain damage is driven by inflammatory processes similar to those observed during RRMS; but that during progressive disease stages, a microenvironment is created within the CNS favouring homing and retention of inflammatory cells, ultimately causing disease-modifying therapies to become largely ineffective (Frischer et al., 2009).",
      "key": "542e4d61e982839e864415dd64c39e6e",
      "line": 108,
      "relation": "increases",
      "source": 68,
      "target": 145
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "1794175b77241bfedc36d52502cbdd21",
      "line": 241,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 157
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "a55e44b2595d99938b377b83364529c8",
      "line": 243,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 165
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "80fe3732fc5899eff87cc250f89a398b",
      "line": 246,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 142
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "cd7476de0c607e93f37f9f3b93285f35",
      "line": 248,
      "relation": "increases",
      "source": 68,
      "target": 174
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "One suggests that brain damage is driven by inflammatory processes similar to those observed during RRMS; but that during progressive disease stages, a microenvironment is created within the CNS favouring homing and retention of inflammatory cells, ultimately causing disease-modifying therapies to become largely ineffective (Frischer et al., 2009).",
      "key": "dd66df89ebc435bd3530220c68a4b946",
      "line": 106,
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "One suggests that brain damage is driven by inflammatory processes similar to those observed during RRMS; but that during progressive disease stages, a microenvironment is created within the CNS favouring homing and retention of inflammatory cells, ultimately causing disease-modifying therapies to become largely ineffective (Frischer et al., 2009).",
      "key": "df0bc84a313e261883b3f91c4f868d3d",
      "line": 107,
      "relation": "positiveCorrelation",
      "source": 63,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Laquinimod, an emerging oral medication for multiple sclerosis (see below) with significant CNS impact, reduces astrocyte activation (Bruck et al., 2012), and inhibits microglial activation in human brain cell cultures.",
      "key": "44f77447fb01d1d50ce0658fcedeee54",
      "line": 451,
      "relation": "association",
      "source": 63,
      "target": 7
    },
    {
      "annotations": {
        "Anatomy": {
          "spinal cord": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Although brain and spinal cord inflammation are present in RRMS, SPMS, and PPMS its extent declines with age and disease duration.",
      "key": "4e102e089ae252bd64367c56401a3396",
      "line": 123,
      "relation": "decreases",
      "source": 145,
      "target": 171
    },
    {
      "annotations": {
        "Anatomy": {
          "spinal cord": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Although brain and spinal cord inflammation are present in RRMS, SPMS, and PPMS its extent declines with age and disease duration.",
      "key": "4d0961bfc315e31a7a93667f1eb83619",
      "line": 119,
      "relation": "increases",
      "source": 153,
      "target": 171
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system gray matter layer": true
        },
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "MRI studies revealed more pronounced grey matter and central atrophy in males, and more advanced white matter atrophy in females (Antulov et al., 2009).",
      "key": "aab6ef2f00ccf8883bfd2de07db62526",
      "line": 679,
      "relation": "increases",
      "source": 153,
      "target": 165
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Cell": {
          "lymphocyte of B lineage": true,
          "plasma cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Indeed, the most active cortical multiple sclerosis lesions are crowded with CD8 + T cells and contain few B cells or plasma cells, suggesting cortical inflammation might correlate with reduction in EBV-infected B/plasma cells numbers (Magliozzi et al., 2013).",
      "key": "1696ef4c2e1e9a37ad6db7c1ffedba81",
      "line": 328,
      "relation": "directlyDecreases",
      "source": 171,
      "target": 148
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "However, it also plays a central role in autoimmune disorders as it can sustain ongoing inflammation once activated (Correale, 2014).",
      "key": "8b69fd63f04401ec12c828b7808db018",
      "line": 409,
      "relation": "association",
      "source": 171,
      "target": 71
    },
    {
      "annotations": {
        "Anatomy": {
          "spinal cord": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Although brain and spinal cord inflammation are present in RRMS, SPMS, and PPMS its extent declines with age and disease duration.",
      "key": "5a3bb5d0f081f4325946fc1d97cfcece",
      "line": 121,
      "relation": "decreases",
      "source": 164,
      "target": 171
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Evidence from both imaging and pathology suggest that the inflammatory demyelinating process in early multiple sclerosis drives a pathogenic cascade of events causing neurodegeneration, which in turn is further amplified by brain ageing, microglial activation and accumulated disease burden (Popescu and Lucchinetti, 2012; Mahad et al., 2015).",
      "key": "8f1c5ccf1fe2367546c0959e4206752b",
      "line": 532,
      "relation": "increases",
      "source": 164,
      "target": 157
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Among potential candidates driving inflammation during progressive multiple sclerosis, the role of B cells appears to be prominent, particularly in the context of meningeal inflammation (Magliozzi et al., 2007).",
      "key": "03ad1f9f55ea8266a9b191881b9ede12",
      "line": 134,
      "relation": "association",
      "source": 139,
      "target": 172
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Among potential candidates driving inflammation during progressive multiple sclerosis, the role of B cells appears to be prominent, particularly in the context of meningeal inflammation (Magliozzi et al., 2007).",
      "key": "dccaae5c6377adeb5962efc63601dae0",
      "line": 134,
      "relation": "association",
      "source": 172,
      "target": 139
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Moreover, in SPMS meningeal inflammation is associated with damage to the glia limitants, and a gradient of neuronal loss is observed that is greater in superficial cortical layers nearer the pial surface than in inner cortical layers (Magliozzi et al., 2010).",
      "key": "d2c4ba397c4af1a5e1780951a4f647bb",
      "line": 262,
      "relation": "increases",
      "source": 172,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",
      "key": "d078a07f1294355e4bb2bcd2f52823a1",
      "line": 285,
      "relation": "increases",
      "source": 172,
      "target": 153
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "B cell functions that could be of relevance in progressive multiple sclerosis include: antibody production, cytokine secretion, antigen presentation and ectopic formation of follicle-like structures, a pathological feature shared with other chronic inflammatory diseases (Aloisi and Pujol-Borrell, 2006).",
      "key": "683de6d7b88a5c37883e2746dfc69edd",
      "line": 146,
      "relation": "increases",
      "source": 114,
      "target": 136
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "B cell functions that could be of relevance in progressive multiple sclerosis include: antibody production, cytokine secretion, antigen presentation and ectopic formation of follicle-like structures, a pathological feature shared with other chronic inflammatory diseases (Aloisi and Pujol-Borrell, 2006).",
      "key": "e050aa76c122757fd2d1991f9893702a",
      "line": 147,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 114,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "B cell functions that could be of relevance in progressive multiple sclerosis include: antibody production, cytokine secretion, antigen presentation and ectopic formation of follicle-like structures, a pathological feature shared with other chronic inflammatory diseases (Aloisi and Pujol-Borrell, 2006).",
      "key": "6d7da1dadffcdc1d41d3dffcddeef2ac",
      "line": 148,
      "relation": "increases",
      "source": 114,
      "target": 137
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "B cell functions that could be of relevance in progressive multiple sclerosis include: antibody production, cytokine secretion, antigen presentation and ectopic formation of follicle-like structures, a pathological feature shared with other chronic inflammatory diseases (Aloisi and Pujol-Borrell, 2006).",
      "key": "511c413595731a764faedffb0dd66742",
      "line": 149,
      "relation": "increases",
      "source": 114,
      "target": 162
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Thus, this compartmental CNS B cell immune response may be able to drive CNS injury independent of peripheral immune activity (Lovato et al., 2011).",
      "key": "89ed8e127642e5397af110614f108863",
      "line": 185,
      "relation": "increases",
      "source": 114,
      "target": 163
    },
    {
      "annotations": {
        "Anatomy": {
          "subarachnoid space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicle-like structures have recently been found in the subarachnoid space of leptomeninges, close to inflamed blood vessels. Composition of these infiltrates included: proliferating B lymphocytes, plasma cells, helper T lymphocytes and a network of follicular dendritic cells (Serafini et al., 2004; Magliozzi et al., 2007).",
      "key": "33363f4a52277896e569840f5a848e80",
      "line": 197,
      "relation": "association",
      "source": 162,
      "target": 10
    },
    {
      "annotations": {
        "Anatomy": {
          "subarachnoid space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicle-like structures have recently been found in the subarachnoid space of leptomeninges, close to inflamed blood vessels. Composition of these infiltrates included: proliferating B lymphocytes, plasma cells, helper T lymphocytes and a network of follicular dendritic cells (Serafini et al., 2004; Magliozzi et al., 2007).",
      "key": "64eb18de6c67a1e488504d3d101cbf67",
      "line": 198,
      "relation": "association",
      "source": 162,
      "target": 17
    },
    {
      "annotations": {
        "Anatomy": {
          "subarachnoid space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicle-like structures have recently been found in the subarachnoid space of leptomeninges, close to inflamed blood vessels. Composition of these infiltrates included: proliferating B lymphocytes, plasma cells, helper T lymphocytes and a network of follicular dendritic cells (Serafini et al., 2004; Magliozzi et al., 2007).",
      "key": "026e3fc7a8783a0c641eafaec0946b4d",
      "line": 199,
      "relation": "association",
      "source": 162,
      "target": 19
    },
    {
      "annotations": {
        "Anatomy": {
          "subarachnoid space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicle-like structures have recently been found in the subarachnoid space of leptomeninges, close to inflamed blood vessels. Composition of these infiltrates included: proliferating B lymphocytes, plasma cells, helper T lymphocytes and a network of follicular dendritic cells (Serafini et al., 2004; Magliozzi et al., 2007).",
      "key": "1f19b15dabb5163274396476e37fb1b5",
      "line": 200,
      "relation": "association",
      "source": 162,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "782eeee3a64ac1af79a8e128bd83bec3",
      "line": 242,
      "relation": "positiveCorrelation",
      "source": 162,
      "target": 157
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "b9feca8c63e152fbd0525da8b5a7244e",
      "line": 244,
      "relation": "positiveCorrelation",
      "source": 162,
      "target": 165
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "3b21154039be694cdd6f26747c82b481",
      "line": 247,
      "relation": "positiveCorrelation",
      "source": 162,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis, Chronic Progressive": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Indeed, presence of follicle-like structure in patients with SPMS has been associated with lower age at disease onset, more severe disability and higher death rates (Magliozzi et al., 2007, 2010; Howell et al., 2011).",
      "key": "818cbf8ef6f6ea10656354f14571ddda",
      "line": 273,
      "relation": "decreases",
      "source": 162,
      "target": 135
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Multiple Sclerosis, Chronic Progressive": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Indeed, presence of follicle-like structure in patients with SPMS has been associated with lower age at disease onset, more severe disability and higher death rates (Magliozzi et al., 2007, 2010; Howell et al., 2011).",
      "key": "90863083a5c19b1207bd34f0cee31d4d",
      "line": 274,
      "relation": "directlyIncreases",
      "source": 162,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",
      "key": "65f2a811077318c0b6cd0d5ff697fe6b",
      "line": 287,
      "relation": "causesNoChange",
      "source": 162,
      "target": 172
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",
      "key": "68627c85827deadc9e660c5122d47e7a",
      "line": 291,
      "relation": "causesNoChange",
      "source": 162,
      "target": 174
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "f53d3183176869c3b0a91cebb82ad1ac",
      "line": 162,
      "relation": "isA",
      "source": 110,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "207bac50366c9eacdaa1e021e6c00faa",
      "line": 167,
      "relation": "positiveCorrelation",
      "source": 110,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "d74e82b8283829ef810a696cf15a6385",
      "line": 172,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 110,
      "target": 128
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "bb49cdac629fa857f7229a4f130ab8ea",
      "line": 425,
      "relation": "directlyDecreases",
      "source": 110,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "98ac4b8aaed301b9d3b0e6f0fcdf68cf",
      "line": 163,
      "relation": "isA",
      "source": 107,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "629427946e5f25f28c66ce3ac1b2edc8",
      "line": 168,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "ccec50b0c52b486b664c01101d2fc090",
      "line": 173,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 128
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "cc811913d394946cebd97f2293d864aa",
      "line": 164,
      "relation": "isA",
      "source": 105,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "bcd8a4a9d5229b1d6689eefa2d8b6715",
      "line": 169,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "11f5e53c982e5b8454b87f142f90c1f6",
      "line": 174,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 128
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "a08023e04c5a88fcba7ef238635c9af3",
      "line": 424,
      "relation": "directlyDecreases",
      "source": 105,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "7305c1238f1a57d51cc51b8a26853bf5",
      "line": 165,
      "relation": "regulates",
      "source": 102,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "15025a5c3ac97280e7f05aec038588b0",
      "line": 170,
      "relation": "negativeCorrelation",
      "source": 102,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "958063056da3ebdcf57671a0ef85e88d",
      "line": 175,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 102,
      "target": 128
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "b4d9d03206bbe7d4ab49e272b9a90836",
      "line": 166,
      "relation": "regulates",
      "source": 84,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "f4340e4548ae8d482ea3daf4847fe4e3",
      "line": 171,
      "relation": "negativeCorrelation",
      "source": 84,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "7f4f714e26dd01d167a101b393cd050e",
      "line": 176,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 84,
      "target": 128
    },
    {
      "key": "6e8d3bf91d4d1f7aeded4e7b56ee59c1",
      "relation": "partOf",
      "source": 94,
      "target": 84
    },
    {
      "key": "e5af7d746e0867dbe656f30fd0b3a379",
      "relation": "partOf",
      "source": 103,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "fbfb2faece6ca3a31658abf1e421ddd5",
      "line": 167,
      "relation": "positiveCorrelation",
      "source": 141,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "ae6794477b93290e5526babd86aa18b4",
      "line": 168,
      "relation": "positiveCorrelation",
      "source": 141,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "f7ff7478c88ff2f68c32e5d5f0aaba42",
      "line": 169,
      "relation": "positiveCorrelation",
      "source": 141,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "d483a33d12b340bbd3bf41b5de675c4d",
      "line": 170,
      "relation": "negativeCorrelation",
      "source": 141,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "77d876f6e08b2a31a6b3dda8775763b2",
      "line": 171,
      "relation": "negativeCorrelation",
      "source": 141,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "a4689ed014d8614cf958f6941742c69f",
      "line": 172,
      "relation": "positiveCorrelation",
      "source": 128,
      "subject": {
        "modifier": "Activity"
      },
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "dc8ed92dc5cf3213c6d9c992777c04a8",
      "line": 173,
      "relation": "positiveCorrelation",
      "source": 128,
      "subject": {
        "modifier": "Activity"
      },
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "284dd1fac3fe6e577f9070c6f6b36e70",
      "line": 174,
      "relation": "positiveCorrelation",
      "source": 128,
      "subject": {
        "modifier": "Activity"
      },
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "020e9c4a2f86a0ad9296e49e56c3c23f",
      "line": 175,
      "relation": "negativeCorrelation",
      "source": 128,
      "subject": {
        "modifier": "Activity"
      },
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, increased secretion of pro-inflammatory cytokines such as lymphotoxin, tumour necrosis factor alpha (TNF-alpha), and interleukin (IL)-6, or deficient production of regulatory cytokines including IL-10 or IL-35 may impact complement activation and T cell function (Bar-Or et al., 2010).",
      "key": "919e71f29d457904eb88899623316216",
      "line": 176,
      "relation": "negativeCorrelation",
      "source": 128,
      "subject": {
        "modifier": "Activity"
      },
      "target": 84
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Thus, this compartmental CNS B cell immune response may be able to drive CNS injury independent of peripheral immune activity (Lovato et al., 2011).",
      "key": "c4ec88d6a2fcb598ede5f56288999fbb",
      "line": 186,
      "object": {
        "modifier": "Activity"
      },
      "relation": "causesNoChange",
      "source": 170,
      "target": 114
    },
    {
      "annotations": {
        "Anatomy": {
          "subarachnoid space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicle-like structures have recently been found in the subarachnoid space of leptomeninges, close to inflamed blood vessels. Composition of these infiltrates included: proliferating B lymphocytes, plasma cells, helper T lymphocytes and a network of follicular dendritic cells (Serafini et al., 2004; Magliozzi et al., 2007).",
      "key": "88b0b2107522332c7fe54cbebe427db7",
      "line": 197,
      "relation": "association",
      "source": 10,
      "target": 162
    },
    {
      "annotations": {
        "Anatomy": {
          "subarachnoid space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicle-like structures have recently been found in the subarachnoid space of leptomeninges, close to inflamed blood vessels. Composition of these infiltrates included: proliferating B lymphocytes, plasma cells, helper T lymphocytes and a network of follicular dendritic cells (Serafini et al., 2004; Magliozzi et al., 2007).",
      "key": "cecaf12efc506157e7f04b3eee4bc05d",
      "line": 198,
      "relation": "association",
      "source": 17,
      "target": 162
    },
    {
      "annotations": {
        "Anatomy": {
          "subarachnoid space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicle-like structures have recently been found in the subarachnoid space of leptomeninges, close to inflamed blood vessels. Composition of these infiltrates included: proliferating B lymphocytes, plasma cells, helper T lymphocytes and a network of follicular dendritic cells (Serafini et al., 2004; Magliozzi et al., 2007).",
      "key": "ddcd4c863df01858c05ac867389ce941",
      "line": 199,
      "relation": "association",
      "source": 19,
      "target": 162
    },
    {
      "annotations": {
        "Anatomy": {
          "subarachnoid space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicle-like structures have recently been found in the subarachnoid space of leptomeninges, close to inflamed blood vessels. Composition of these infiltrates included: proliferating B lymphocytes, plasma cells, helper T lymphocytes and a network of follicular dendritic cells (Serafini et al., 2004; Magliozzi et al., 2007).",
      "key": "ea35b8cbd93ee4feebad0720e04c3eb2",
      "line": 200,
      "relation": "association",
      "source": 12,
      "target": 162
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicular dendritic cells within follicle-like structure produce CXCL13, which is important for recruitment, as well as maturation and antigenic selection of B cells (Corsiero et al., 2012).",
      "key": "b95bbe88ec9c6d9ca705419c06181a72",
      "line": 209,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 12,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicular dendritic cells within follicle-like structure produce CXCL13, which is important for recruitment, as well as maturation and antigenic selection of B cells (Corsiero et al., 2012).",
      "key": "ca647a19d1c1dc636e23caf2e969d744",
      "line": 210,
      "relation": "positiveCorrelation",
      "source": 93,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicular dendritic cells within follicle-like structure produce CXCL13, which is important for recruitment, as well as maturation and antigenic selection of B cells (Corsiero et al., 2012).",
      "key": "e6e7140bd8f436b6eb43fb5b0b4613ae",
      "line": 211,
      "relation": "positiveCorrelation",
      "source": 93,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicular dendritic cells within follicle-like structure produce CXCL13, which is important for recruitment, as well as maturation and antigenic selection of B cells (Corsiero et al., 2012).",
      "key": "31468cde825c997d602e1ae3610653ae",
      "line": 212,
      "relation": "positiveCorrelation",
      "source": 93,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicular dendritic cells within follicle-like structure produce CXCL13, which is important for recruitment, as well as maturation and antigenic selection of B cells (Corsiero et al., 2012).",
      "key": "2f7bb6f8a2e173bf4362bed919a69d4a",
      "line": 210,
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicular dendritic cells within follicle-like structure produce CXCL13, which is important for recruitment, as well as maturation and antigenic selection of B cells (Corsiero et al., 2012).",
      "key": "021cc62504ca658d25c6e1b10894dd1b",
      "line": 211,
      "relation": "positiveCorrelation",
      "source": 79,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Follicular dendritic cells within follicle-like structure produce CXCL13, which is important for recruitment, as well as maturation and antigenic selection of B cells (Corsiero et al., 2012).",
      "key": "98d81a9eacefaac2ec390cf9c9b5c825",
      "line": 212,
      "relation": "positiveCorrelation",
      "source": 54,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Notably, follicle- like structures are probably able to sustain a high level of humoral response, as well as other autoimmune mechanisms within the CNS, in a manner independent of peripheral inflammation.",
      "key": "dbf91af3682d38c24164c718fc1ec5ec",
      "line": 231,
      "relation": "causesNoChange",
      "source": 149,
      "target": 162
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "66679e0bd790e95e1f07c08e72acbe3c",
      "line": 243,
      "relation": "positiveCorrelation",
      "source": 165,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, cortical demyelination, neurodegeneration and atrophy show positive correlation with diffuse inflammatory infiltrates and lymphoid follicle-like structure in leptomeninges, indicating immune activation in this compartment contributes to cortical pathology in multiple sclerosis (Lassmann et al., 2007; Magliozzi et al., 2007, 2010).",
      "key": "db51b6a6cc693860b23647dc290f59f6",
      "line": 244,
      "relation": "positiveCorrelation",
      "source": 165,
      "target": 162
    },
    {
      "annotations": {
        "Anatomy": {
          "spinal cord gray commissure": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Notably, spinal cord grey matter atrophy seems to contribute more to patient disability than spinal cord white matter or brain grey matter atrophy (Schlaeger et al., 2014).",
      "key": "4e9917ced9e8fa514c403228e4bce6a9",
      "line": 724,
      "relation": "increases",
      "source": 165,
      "target": 143
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",
      "key": "dacb0cf3bd10363572d2dd0dfafd83a8",
      "line": 289,
      "relation": "increases",
      "source": 174,
      "target": 153
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It is known that DMF reduces oxidative stress related to neuronal death and myelin damage, via the Nrf2 pathway, making DMF a potential therapeutic option for progressive multiple sclerosis (Strassburger- Krogias et al., 2014).",
      "key": "0c9988b9f1fad80003ddbca3e39303e2",
      "line": 871,
      "relation": "association",
      "source": 74,
      "target": 160
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, expression of EBV lytic proteins BZLF1 and BERF1 was found to be restricted to plasma cells located in active cortical lesions (Magliozzi et al., 2013)",
      "key": "1b01253423d1129e078f7dfa92c9f335",
      "line": 304,
      "object": {
        "location": {
          "name": "Plasma Cells",
          "namespace": "MESH"
        }
      },
      "relation": "association",
      "source": 148,
      "target": 132
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It is interesting to note that early lytic EBV antigens elicited CD8-mediated immune responses, triggering strong cytotoxic effects on brain tissue (Hislop et al., 2007).",
      "key": "7391d0b1e6a41dd218f0f60d7189ac45",
      "line": 313,
      "relation": "directlyIncreases",
      "source": 148,
      "target": 55
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, expression of EBV lytic proteins BZLF1 and BERF1 was found to be restricted to plasma cells located in active cortical lesions (Magliozzi et al., 2013)",
      "key": "71dd4c8b8d37a4b4921818084fe77774",
      "line": 304,
      "relation": "association",
      "source": 132,
      "subject": {
        "location": {
          "name": "Plasma Cells",
          "namespace": "MESH"
        }
      },
      "target": 148
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It is interesting to note that early lytic EBV antigens elicited CD8-mediated immune responses, triggering strong cytotoxic effects on brain tissue (Hislop et al., 2007).",
      "key": "44496023117e6529ed93922028a039f0",
      "line": 315,
      "relation": "directlyIncreases",
      "source": 55,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Cytotoxic T lymphocytes release pro-inflammatory cytokines such as TNF-alpha and interferon (IFN)-gamma, as well as perforin, and granzymes A and B, among others (Huse et al., 2008; Mizuno et al., 2008; Meuth et al., 2009).",
      "key": "f2860ec64a597bd5489e5b18a48eaeab",
      "line": 338,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 18,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Cytotoxic T lymphocytes release pro-inflammatory cytokines such as TNF-alpha and interferon (IFN)-gamma, as well as perforin, and granzymes A and B, among others (Huse et al., 2008; Mizuno et al., 2008; Meuth et al., 2009).",
      "key": "4252eb938df25807777fff7df1fa7a7d",
      "line": 339,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 18,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Cytotoxic T lymphocytes release pro-inflammatory cytokines such as TNF-alpha and interferon (IFN)-gamma, as well as perforin, and granzymes A and B, among others (Huse et al., 2008; Mizuno et al., 2008; Meuth et al., 2009).",
      "key": "b85794ccbf1e7dd022e26a66ec9d865d",
      "line": 340,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 18,
      "target": 109
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Cytotoxic T lymphocytes release pro-inflammatory cytokines such as TNF-alpha and interferon (IFN)-gamma, as well as perforin, and granzymes A and B, among others (Huse et al., 2008; Mizuno et al., 2008; Meuth et al., 2009).",
      "key": "7fcf69946793581b166a47066fdab013",
      "line": 341,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 18,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Cytotoxic T lymphocytes release pro-inflammatory cytokines such as TNF-alpha and interferon (IFN)-gamma, as well as perforin, and granzymes A and B, among others (Huse et al., 2008; Mizuno et al., 2008; Meuth et al., 2009).",
      "key": "b0d4f62e9bc09fa88bdd11dc2ce62e0a",
      "line": 342,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 18,
      "target": 99
    },
    {
      "key": "2d4de3fd7a6ba6717ae769f18dc5de03",
      "relation": "partOf",
      "source": 18,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "IFN-gamma on the other hand, increases glutamate neurotoxicity and calcium influx into neurons through modulating the IFN-gamma/AMPA GluR1 complex (Mizuno et al., 2008).",
      "key": "38da526375c09d099dfddf0f40875727",
      "line": 356,
      "relation": "negativeCorrelation",
      "source": 100,
      "target": 67
    },
    {
      "key": "7571d2108e690920726ca5a5635a5e11",
      "relation": "partOf",
      "source": 100,
      "target": 85
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "7055f7f8a0d7dc476bab88c79fa41224",
      "line": 426,
      "relation": "directlyDecreases",
      "source": 100,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Perforin and granzyme directly damage the membrane, causing sodium and calcium influx that ultimately leads to energy breakdown within the cell.",
      "key": "45435637698d1ec2c6df56ef9b52010c",
      "line": 367,
      "relation": "increases",
      "source": 109,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Perforin and granzyme directly damage the membrane, causing sodium and calcium influx that ultimately leads to energy breakdown within the cell.",
      "key": "b51386e1e3083bf64c3a39c520c0b15a",
      "line": 370,
      "relation": "increases",
      "source": 109,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Perforin and granzyme directly damage the membrane, causing sodium and calcium influx that ultimately leads to energy breakdown within the cell.",
      "key": "8817b0836029d03f72cb37dba018af26",
      "line": 368,
      "relation": "increases",
      "source": 98,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Perforin and granzyme directly damage the membrane, causing sodium and calcium influx that ultimately leads to energy breakdown within the cell.",
      "key": "c745c389524dcb5ad845c5d282418a5a",
      "line": 371,
      "relation": "increases",
      "source": 98,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Perforin and granzyme directly damage the membrane, causing sodium and calcium influx that ultimately leads to energy breakdown within the cell.",
      "key": "ad4c81ff483ef961cf548279c20c5106",
      "line": 369,
      "relation": "increases",
      "source": 99,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Perforin and granzyme directly damage the membrane, causing sodium and calcium influx that ultimately leads to energy breakdown within the cell.",
      "key": "26044c018554bfede9cea43f9bd59778",
      "line": 372,
      "relation": "increases",
      "source": 99,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "TNF-alpha for instance, can trigger cell death via the p55 receptor on neurons (Venters et al., 2000).",
      "key": "0e0e35048dc0c2b7caff3fa73c605c4f",
      "line": 348,
      "relation": "increases",
      "source": 111,
      "subject": {
        "location": {
          "name": "Neurons",
          "namespace": "MESH"
        }
      },
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "IFN-gamma on the other hand, increases glutamate neurotoxicity and calcium influx into neurons through modulating the IFN-gamma/AMPA GluR1 complex (Mizuno et al., 2008).",
      "key": "3bc023ae2a8043de55c9425f9fa9efa9",
      "line": 356,
      "relation": "negativeCorrelation",
      "source": 67,
      "target": 100
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "IFN-gamma on the other hand, increases glutamate neurotoxicity and calcium influx into neurons through modulating the IFN-gamma/AMPA GluR1 complex (Mizuno et al., 2008).",
      "key": "74075bd1e8a5f39bc6e74a7507da6310",
      "line": 358,
      "relation": "regulates",
      "source": 85,
      "target": 61
    },
    {
      "key": "52e1a882f875f68b8e031e20fd1773ef",
      "relation": "partOf",
      "source": 113,
      "target": 85
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Perforin and granzyme directly damage the membrane, causing sodium and calcium influx that ultimately leads to energy breakdown within the cell.",
      "key": "9b89b3cb3842e35a82914f9aaa90d1c5",
      "line": 373,
      "relation": "increases",
      "source": 61,
      "target": 147
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Perforin and granzyme directly damage the membrane, causing sodium and calcium influx that ultimately leads to energy breakdown within the cell.",
      "key": "059524170a19abe2ab9e31145500abba",
      "line": 374,
      "relation": "increases",
      "source": 81,
      "target": 147
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "However, when mitochondrial injury surpasses a certain threshold, energy deficiency will lead to axonal degeneration and cell death (Friese et al., 2014).",
      "key": "47d0c2975ef2e742061d89b1a86043d2",
      "line": 598,
      "relation": "directlyDecreases",
      "source": 147,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "However, when mitochondrial injury surpasses a certain threshold, energy deficiency will lead to axonal degeneration and cell death (Friese et al., 2014).",
      "key": "5d5516927e352fa4b4ebc5ae7d315b4d",
      "line": 599,
      "relation": "directlyDecreases",
      "source": 147,
      "target": 62
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, interaction of Fas antigen on cytotoxic T lymphocyte with Fas ligand on neurons is an additional mechanism activating the intracellular caspase cascade causing axonal/neuronal damage (Medana et al., 2000; Giuliani et al., 2003).",
      "key": "4b6d0d388d2a328efad3bc203de525ad",
      "line": 384,
      "relation": "increases",
      "source": 96,
      "target": 86
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, interaction of Fas antigen on cytotoxic T lymphocyte with Fas ligand on neurons is an additional mechanism activating the intracellular caspase cascade causing axonal/neuronal damage (Medana et al., 2000; Giuliani et al., 2003).",
      "key": "bbe7399fa924952d639bcdf1cd44928d",
      "line": 385,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 86,
      "target": 24
    },
    {
      "key": "cbcc2f04841858a7648de6255503bb90",
      "relation": "partOf",
      "source": 95,
      "target": 86
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, interaction of Fas antigen on cytotoxic T lymphocyte with Fas ligand on neurons is an additional mechanism activating the intracellular caspase cascade causing axonal/neuronal damage (Medana et al., 2000; Giuliani et al., 2003).",
      "key": "f1ac56cdda60b2c37216c77237826661",
      "line": 386,
      "relation": "increases",
      "source": 24,
      "subject": {
        "modifier": "Activity"
      },
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Active demyelination and neurodegeneration have also been linked to microglial activation in early lesions with accumulation of macrophages in injured tissues (Lassmann, 2014).",
      "key": "c38fdff9abf1524c33859f31f504d7b0",
      "line": 392,
      "relation": "association",
      "source": 155,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because NAA is detected almost exclusively in neurons and their processes, decreased levels of this metabolite have been interpreted as evidence of axonal injury.",
      "key": "4cf53c1ed92eb10c4de7c54f518a464c",
      "line": 711,
      "relation": "association",
      "source": 155,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Active demyelination and neurodegeneration have also been linked to microglial activation in early lesions with accumulation of macrophages in injured tissues (Lassmann, 2014).",
      "key": "eeb0cfc25a84724b6a02d6e6221fcfa7",
      "line": 392,
      "relation": "association",
      "source": 71,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Active demyelination and neurodegeneration have also been linked to microglial activation in early lesions with accumulation of macrophages in injured tissues (Lassmann, 2014).",
      "key": "d2573e5db2a54556a69752d935ecbb9d",
      "line": 393,
      "relation": "association",
      "source": 71,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Active demyelination and neurodegeneration have also been linked to microglial activation in early lesions with accumulation of macrophages in injured tissues (Lassmann, 2014).",
      "key": "4b2f91ac1d389aecd743869c5d07a98c",
      "line": 395,
      "relation": "directlyIncreases",
      "source": 71,
      "target": 27
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Under normal circumstances, inactive microglia contributes to neuronal compartment homeostasis.",
      "key": "543e641ecc3d801a02593fa30aa4e127",
      "line": 402,
      "relation": "decreases",
      "source": 71,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "However, it also plays a central role in autoimmune disorders as it can sustain ongoing inflammation once activated (Correale, 2014).",
      "key": "e4c47d57e9fed214c13ed609d22ee6db",
      "line": 409,
      "relation": "association",
      "source": 71,
      "target": 171
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "However, it also plays a central role in autoimmune disorders as it can sustain ongoing inflammation once activated (Correale, 2014).",
      "key": "bf0a9fff9d99b1dc1f2dbe2f9007165e",
      "line": 410,
      "relation": "association",
      "source": 71,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "cb73dd9d13348f0f4aa2a40ea97e0985",
      "line": 416,
      "relation": "decreases",
      "source": 71,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "22abef379e7f996508bc26a54b9ccc99",
      "line": 417,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 71,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "22414c98537f3ba56c9b6ac8cb63e446",
      "line": 418,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 71,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "86668e3a12ba3a575e0188bb5598d2da",
      "line": 419,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 71,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "6182ac1c7df3d463756d43b8e6aa96bb",
      "line": 420,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 71,
      "target": 100
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "40ef1d088a0636c9122b0d0936982674",
      "line": 421,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 71,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "1ca410cf0fedd414fc57cd6cfdab6a02",
      "line": 422,
      "relation": "positiveCorrelation",
      "source": 71,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It is interesting to note that activated microglia possess a puzzling array of neuroprotective functions as well, including debris phagocytosis and clearance, elaboration of growth factors and neuronal circuit-shaping (Arnett et al., 2001; Kotter et al., 2001; Correale, 2014).",
      "key": "d6f791668243f65eabef289304a85af5",
      "line": 443,
      "relation": "increases",
      "source": 71,
      "target": 173
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It is interesting to note that activated microglia possess a puzzling array of neuroprotective functions as well, including debris phagocytosis and clearance, elaboration of growth factors and neuronal circuit-shaping (Arnett et al., 2001; Kotter et al., 2001; Correale, 2014).",
      "key": "e0baf6ebde857cb0d8a2b49238a91e10",
      "line": 444,
      "relation": "increases",
      "source": 71,
      "target": 175
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It is interesting to note that activated microglia possess a puzzling array of neuroprotective functions as well, including debris phagocytosis and clearance, elaboration of growth factors and neuronal circuit-shaping (Arnett et al., 2001; Kotter et al., 2001; Correale, 2014).",
      "key": "befe37b31e394891d6942334d56b207a",
      "line": 445,
      "relation": "increases",
      "source": 71,
      "target": 75
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "LacCer promotes astrocyte activation, leading to granulocyte-macrophage colony-stimulating factor (GMCSF, encoded by CSF2) and CCL2 gene induction, consequently activating microglia and causing infiltration of monocytes from the peripheral blood.",
      "key": "b73a24256a867b5a98505ba3c4719e79",
      "line": 514,
      "relation": "increases",
      "source": 71,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Evidence from both imaging and pathology suggest that the inflammatory demyelinating process in early multiple sclerosis drives a pathogenic cascade of events causing neurodegeneration, which in turn is further amplified by brain ageing, microglial activation and accumulated disease burden (Popescu and Lucchinetti, 2012; Mahad et al., 2015).",
      "key": "61dd4c28f0046451516523530e40f22f",
      "line": 531,
      "relation": "increases",
      "source": 71,
      "target": 157
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "364e7fcbce591ff0e56991b0bbf7f6e0",
      "line": 547,
      "relation": "directlyIncreases",
      "source": 27,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "1706c433c4c58814093a2e989aba0dbe",
      "line": 548,
      "relation": "directlyIncreases",
      "source": 27,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "0d1b23b90fa2d911610e2ff9e1a3b2ac",
      "line": 549,
      "relation": "directlyIncreases",
      "source": 27,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "However, it also plays a central role in autoimmune disorders as it can sustain ongoing inflammation once activated (Correale, 2014).",
      "key": "6c517b28021983648b9505873eee9206",
      "line": 410,
      "relation": "association",
      "source": 138,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In addition, non-toxic ferric iron is released into the extracellular space from damaged oligodendrocytes in multiple sclerosis lesions, where it undergoes transformation to the divalent ferrous form, further increasing ROS toxicity (Hametner et al., 2013).",
      "key": "855727c630c77f07aae847c5f052c7a3",
      "line": 614,
      "object": {
        "location": {
          "name": "extracellular space",
          "namespace": "GO"
        }
      },
      "relation": "directlyDecreases",
      "source": 30,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "GDNF (glial-cell-line derived neurotrophic factor), IGF1, and BDNF are implicated in trophic support provided for axons by oligodendrocytes (Wilkins et al., 2003), which one would predict would be deficient in multiple sclerosis.",
      "key": "61fd93af84644851149cc1dccdc39b09",
      "line": 834,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "directlyIncreases",
      "source": 30,
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "GDNF (glial-cell-line derived neurotrophic factor), IGF1, and BDNF are implicated in trophic support provided for axons by oligodendrocytes (Wilkins et al., 2003), which one would predict would be deficient in multiple sclerosis.",
      "key": "2fd98b827f6af1e3501ac6dd79cd7958",
      "line": 835,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "directlyIncreases",
      "source": 30,
      "target": 101
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "GDNF (glial-cell-line derived neurotrophic factor), IGF1, and BDNF are implicated in trophic support provided for axons by oligodendrocytes (Wilkins et al., 2003), which one would predict would be deficient in multiple sclerosis.",
      "key": "a2326c73a1ee848b381a852af8ed264c",
      "line": 836,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "directlyIncreases",
      "source": 30,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "678f6b1b511581809d9b23368a54caa1",
      "line": 423,
      "relation": "directlyDecreases",
      "source": 104,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "7482165231337bc4e32aeb24c09a4dc5",
      "line": 427,
      "relation": "directlyDecreases",
      "source": 31,
      "subject": {
        "modifier": "Activity"
      },
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "2379f63ee409414c3b73422c78236e63",
      "line": 422,
      "relation": "positiveCorrelation",
      "source": 80,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",
      "key": "0bfc8c20c3d6a2890f25107c2cdd9381",
      "line": 428,
      "relation": "directlyDecreases",
      "source": 80,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In addition, direct damage to neurons occurs through reactive oxygen and nitrogen species (ROS/NRS) produced by microglia, inducing mitochondrial dysfunction",
      "key": "8e1c000074019bae09ac4d54403fd8fc",
      "line": 434,
      "relation": "directlyIncreases",
      "source": 5,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "0976129413688288b6339d0cd16f7099",
      "line": 544,
      "relation": "isA",
      "source": 5,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Second, mitochondrial injury may amplify oxidative stress through release of oxygen radicals generated as a result of impaired respiratory chain function, thus establishing a vicious cycle of tissue destruction (Murphy, 2009)",
      "key": "e83f732f5f6e379d0214840c5dd52ca0",
      "line": 607,
      "relation": "directlyIncreases",
      "source": 5,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "First, mitochondrial dysfunction results in energy deficiency, which in mild forms will induce functional disturbances in the absence of structural damage.",
      "key": "84cb2ff5f1fc401a602aaa77a2eb69b9",
      "line": 592,
      "relation": "decreases",
      "source": 151,
      "target": 147
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "First, mitochondrial dysfunction results in energy deficiency, which in mild forms will induce functional disturbances in the absence of structural damage.",
      "key": "1d91cc341335ec62f8ca36292c1594ea",
      "line": 593,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 151,
      "target": 129
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Second, mitochondrial injury may amplify oxidative stress through release of oxygen radicals generated as a result of impaired respiratory chain function, thus establishing a vicious cycle of tissue destruction (Murphy, 2009)",
      "key": "40d8ff0f0473fbb41cf5b4b5deed7cce",
      "line": 605,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 151,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In addition, direct damage to neurons occurs through reactive oxygen and nitrogen species (ROS/NRS) produced by microglia, inducing mitochondrial dysfunction",
      "key": "08b98e7c3e01e4e3d638bf6fb8de3ab7",
      "line": 435,
      "relation": "directlyIncreases",
      "source": 4,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "bb280d0e371958409464766364880a69",
      "line": 545,
      "relation": "isA",
      "source": 4,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In addition, direct damage to neurons occurs through reactive oxygen and nitrogen species (ROS/NRS) produced by microglia, inducing mitochondrial dysfunction",
      "key": "6e05baa48fddca931dc7908b8665f7f7",
      "line": 436,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "directlyIncreases",
      "source": 28,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "bd80b16e49a67d7440ee5d458af1e37b",
      "line": 550,
      "relation": "directlyIncreases",
      "source": 28,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In addition, direct damage to neurons occurs through reactive oxygen and nitrogen species (ROS/NRS) produced by microglia, inducing mitochondrial dysfunction",
      "key": "6f9316ef519ddfe411b09db523904833",
      "line": 437,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "directlyIncreases",
      "source": 28,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "3298a3d100d194e3e3d52683763e459b",
      "line": 551,
      "relation": "directlyIncreases",
      "source": 28,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "d1d7cbd604bdef923b6136bd1721b88f",
      "line": 552,
      "relation": "directlyIncreases",
      "source": 28,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Also laquinimod has neuroprotective potential that may depend, at least in part, on its effects on astrocytes and microglia (Bruck et al., 2012; Mishra et al., 2014).",
      "key": "f397a60278a2a7b0008c36af7aec876a",
      "line": 855,
      "relation": "association",
      "source": 28,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Laquinimod, an emerging oral medication for multiple sclerosis (see below) with significant CNS impact, reduces astrocyte activation (Bruck et al., 2012), and inhibits microglial activation in human brain cell cultures.",
      "key": "ee15e316359c23553fd68d7753e925f4",
      "line": 450,
      "relation": "decreases",
      "source": 7,
      "target": 152
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Laquinimod, an emerging oral medication for multiple sclerosis (see below) with significant CNS impact, reduces astrocyte activation (Bruck et al., 2012), and inhibits microglial activation in human brain cell cultures.",
      "key": "26622bd7df982de14f0dca788b859253",
      "line": 451,
      "relation": "association",
      "source": 7,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Laquinimod, an emerging oral medication for multiple sclerosis (see below) with significant CNS impact, reduces astrocyte activation (Bruck et al., 2012), and inhibits microglial activation in human brain cell cultures.",
      "key": "17ddf5750c380ae877f4762c406b2d0a",
      "line": 452,
      "relation": "decreases",
      "source": 7,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Laquinimod, an emerging oral medication for multiple sclerosis (see below) with significant CNS impact, reduces astrocyte activation (Bruck et al., 2012), and inhibits microglial activation in human brain cell cultures.",
      "key": "06fa76e8f8346f36071c4a70e5de6372",
      "line": 455,
      "relation": "directlyDecreases",
      "source": 7,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It reduces both pro- and anti-inflammatory cytokine levels, while growth factor secretion remains high.",
      "key": "4e2dd988d5bce04711409af49e5e6df4",
      "line": 463,
      "relation": "decreases",
      "source": 7,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It reduces both pro- and anti-inflammatory cytokine levels, while growth factor secretion remains high.",
      "key": "984af923b665481ae84f3ec26b9efad5",
      "line": 464,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "causesNoChange",
      "source": 7,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true,
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, a reduction in microglial/macrophage density has been observed in experimental autoimmune encephalomyelitis (EAE) animals treated with laquinimod, ultimately preventing axonal injury and demyelination progression (Mishra et al., 2014).",
      "key": "d41038f1ba9e3fedf25412d3a58f22cf",
      "line": 473,
      "relation": "decreases",
      "source": 7,
      "target": 161
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, a reduction in microglial/macrophage density has been observed in experimental autoimmune encephalomyelitis (EAE) animals treated with laquinimod, ultimately preventing axonal injury and demyelination progression (Mishra et al., 2014).",
      "key": "42a1ec19f179f4a7acdf9cdac99c64bd",
      "line": 475,
      "relation": "decreases",
      "source": 7,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Furthermore, a reduction in microglial/macrophage density has been observed in experimental autoimmune encephalomyelitis (EAE) animals treated with laquinimod, ultimately preventing axonal injury and demyelination progression (Mishra et al., 2014).",
      "key": "6165de7237dd5bec3975bdf91364d2fe",
      "line": 476,
      "relation": "decreases",
      "source": 7,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Recent investigations have demonstrated that in chronic phases of EAE, astrocyte depletion ameliorates disease severity, a deleterious effects mediated by preferential expression of 4-galactosyltransferase 5 and 6 (B4GALT5 and B4GALT6; Mayo et al., 2014).",
      "key": "a1c380d96afeebb0145682df5a8f83ef",
      "line": 482,
      "relation": "directlyDecreases",
      "source": 58,
      "target": 169
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Notably, in human multiple sclerosis lesions BAGALT6 is expressed by reactive astrocytes.",
      "key": "e7ee69b93b1f8546c472dbc1d0d9ca97",
      "line": 491,
      "relation": "increases",
      "source": 58,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "LacCer promotes astrocyte activation, leading to granulocyte-macrophage colony-stimulating factor (GMCSF, encoded by CSF2) and CCL2 gene induction, consequently activating microglia and causing infiltration of monocytes from the peripheral blood.",
      "key": "c44c3c7e07612a48cf4cc8d3bf76f5e2",
      "line": 510,
      "relation": "directlyIncreases",
      "source": 58,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "LacCer promotes astrocyte activation, leading to granulocyte-macrophage colony-stimulating factor (GMCSF, encoded by CSF2) and CCL2 gene induction, consequently activating microglia and causing infiltration of monocytes from the peripheral blood.",
      "key": "72d6d055bc7b78d737e2ae506230b06c",
      "line": 511,
      "relation": "directlyIncreases",
      "source": 58,
      "target": 87
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Recent investigations have demonstrated that in chronic phases of EAE, astrocyte depletion ameliorates disease severity, a deleterious effects mediated by preferential expression of 4-galactosyltransferase 5 and 6 (B4GALT5 and B4GALT6; Mayo et al., 2014).",
      "key": "b9b7b583f5ec519887dbf170574cfdde",
      "line": 483,
      "relation": "directlyIncreases",
      "source": 90,
      "target": 169
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "These enzymes synthesize the signalling molecule lactosylceramide (LacCer), which is significantly increased in the CNS during progressive phases of EAE.",
      "key": "e2a3e91db4ac8bfa76f0ca7f10ad35a8",
      "line": 500,
      "relation": "increases",
      "source": 90,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Recent investigations have demonstrated that in chronic phases of EAE, astrocyte depletion ameliorates disease severity, a deleterious effects mediated by preferential expression of 4-galactosyltransferase 5 and 6 (B4GALT5 and B4GALT6; Mayo et al., 2014).",
      "key": "65abf4f491144d404abe360615001118",
      "line": 484,
      "relation": "directlyIncreases",
      "source": 91,
      "target": 169
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "These enzymes synthesize the signalling molecule lactosylceramide (LacCer), which is significantly increased in the CNS during progressive phases of EAE.",
      "key": "d0735ee51b04d93a404c6ad605d4e0e2",
      "line": 501,
      "relation": "increases",
      "source": 91,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Remarkably, inhibition of B4galt6 in mice suppresses disease progression and neurodegeneration in EAE (Mayo et al., 2014).",
      "key": "9df8404c0251727a487b4c03919f0b71",
      "line": 521,
      "relation": "increases",
      "source": 91,
      "target": 146
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Remarkably, inhibition of B4galt6 in mice suppresses disease progression and neurodegeneration in EAE (Mayo et al., 2014).",
      "key": "663032a464e531ac59339816c32d3bd7",
      "line": 522,
      "relation": "increases",
      "source": 91,
      "target": 157
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "LacCer promotes astrocyte activation, leading to granulocyte-macrophage colony-stimulating factor (GMCSF, encoded by CSF2) and CCL2 gene induction, consequently activating microglia and causing infiltration of monocytes from the peripheral blood.",
      "key": "b3726495959fda7c323ca65e4743ae80",
      "line": 509,
      "relation": "directlyIncreases",
      "source": 38,
      "target": 58
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "These enzymes synthesize the signalling molecule lactosylceramide (LacCer), which is significantly increased in the CNS during progressive phases of EAE.",
      "key": "32c22ad6f516dc5284e860d8b4a2e0cc",
      "line": 503,
      "relation": "directlyIncreases",
      "source": 146,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "LacCer promotes astrocyte activation, leading to granulocyte-macrophage colony-stimulating factor (GMCSF, encoded by CSF2) and CCL2 gene induction, consequently activating microglia and causing infiltration of monocytes from the peripheral blood.",
      "key": "b3dc053cc4c73496e28e6aef80ede1f4",
      "line": 512,
      "relation": "increases",
      "source": 88,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "LacCer promotes astrocyte activation, leading to granulocyte-macrophage colony-stimulating factor (GMCSF, encoded by CSF2) and CCL2 gene induction, consequently activating microglia and causing infiltration of monocytes from the peripheral blood.",
      "key": "d5e31292248559398ef2fa694bbfdd71",
      "line": 513,
      "relation": "increases",
      "source": 87,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "036017b1660c2cd061ac1e3fd8b55586",
      "line": 541,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "directlyIncreases",
      "source": 56,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "5cf06378e9107db2272007df65bb8d49",
      "line": 542,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "directlyIncreases",
      "source": 56,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "dc610a679fdc8c8f85ae809da54981f1",
      "line": 543,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "directlyIncreases",
      "source": 56,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "8916160619801a24f9f5351b33934e21",
      "line": 546,
      "relation": "isA",
      "source": 3,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10114": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "NO has been shown to cause irreversible conduction blockade in axons and to drive spinal cord degeneration in rats (Smith et al., 2001).",
      "key": "0996e55850a1f813ed8de16286dde5f2",
      "line": 563,
      "relation": "decreases",
      "source": 3,
      "target": 156
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10114": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "NO has been shown to cause irreversible conduction blockade in axons and to drive spinal cord degeneration in rats (Smith et al., 2001).",
      "key": "3737744c26416a1daa3ae47b5dbd1627",
      "line": 564,
      "relation": "decreases",
      "source": 3,
      "target": 82
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "e4d708c36cb501f4435cb64760a3d0e8",
      "line": 553,
      "relation": "directlyIncreases",
      "source": 21,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "1ea25b3b476d629ad39a95bd69395f88",
      "line": 554,
      "relation": "directlyIncreases",
      "source": 21,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because pathology findings and number of transected axons correlate with degree of inflammation in acute multiple sclerosis lesions (Trapp et al., 1998; Frischer et al., 2009), great interest has been focused on neurotoxic products released by innate immune cells, particularly ROS, RNS and nitric oxide (NO) produced by macrophages, microglia, and astrocytes, both in multiple sclerosis and in EAE (Haider et al., 2011).",
      "key": "95150d87a49b395b56ac96ed5ab4f298",
      "line": 555,
      "relation": "directlyIncreases",
      "source": 21,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Also laquinimod has neuroprotective potential that may depend, at least in part, on its effects on astrocytes and microglia (Bruck et al., 2012; Mishra et al., 2014).",
      "key": "82b3b4b59b4728ee4b48fa673b508f93",
      "line": 856,
      "relation": "association",
      "source": 21,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In turn, scavengers reducing ROS and RNS levels in EAE were able to attenuate focal axonal degeneration without altering the number of immune cells is EAE lesions.",
      "key": "68a3255338fefe992bf5f5a1bc6d1c92",
      "line": 572,
      "relation": "directlyDecreases",
      "source": 13,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In turn, scavengers reducing ROS and RNS levels in EAE were able to attenuate focal axonal degeneration without altering the number of immune cells is EAE lesions.",
      "key": "3d47bf403d9747066cd7cda5c2bbb89d",
      "line": 573,
      "relation": "directlyDecreases",
      "source": 13,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In turn, scavengers reducing ROS and RNS levels in EAE were able to attenuate focal axonal degeneration without altering the number of immune cells is EAE lesions.",
      "key": "d7fb6dd5636670655c3a3c52bd38b04a",
      "line": 574,
      "relation": "causesNoChange",
      "source": 13,
      "target": 170
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Second, mitochondrial injury may amplify oxidative stress through release of oxygen radicals generated as a result of impaired respiratory chain function, thus establishing a vicious cycle of tissue destruction (Murphy, 2009)",
      "key": "c0962d5675439cde52d82aa1f31f05de",
      "line": 606,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "directlyDecreases",
      "source": 117,
      "subject": {
        "modifier": "Activity"
      },
      "target": 5
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Neuronal cell bodies in deeper layers of the cortex show evidence of impaired functional activity of mitochondrial respiratory chain complexes (Campbell et al., 2011), as well as alterations in motor proteins (encoded by nuclear DNA) responsible for the movement of the mitochondria from cell body to axons (Campbell et al., 2014).",
      "key": "810a10241aba606acaeb3738ebbc52b9",
      "line": 585,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "cell body",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "axon",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "directlyIncreases",
      "source": 121,
      "target": 129
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It is known that DMF reduces oxidative stress related to neuronal death and myelin damage, via the Nrf2 pathway, making DMF a potential therapeutic option for progressive multiple sclerosis (Strassburger- Krogias et al., 2014).",
      "key": "eb816fa4acd5eadc570e367292b1753c",
      "line": 871,
      "relation": "association",
      "source": 160,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It is known that DMF reduces oxidative stress related to neuronal death and myelin damage, via the Nrf2 pathway, making DMF a potential therapeutic option for progressive multiple sclerosis (Strassburger- Krogias et al., 2014).",
      "key": "2ed616242951026812adbc0748882989",
      "line": 872,
      "relation": "negativeCorrelation",
      "source": 160,
      "target": 73
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In addition, non-toxic ferric iron is released into the extracellular space from damaged oligodendrocytes in multiple sclerosis lesions, where it undergoes transformation to the divalent ferrous form, further increasing ROS toxicity (Hametner et al., 2013).",
      "key": "891c7f9eb36954cb3ad0eae88b6b1a30",
      "line": 615,
      "object": {
        "location": {
          "name": "extracellular space",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 2,
      "subject": {
        "location": {
          "name": "extracellular space",
          "namespace": "GO"
        }
      },
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In addition, non-toxic ferric iron is released into the extracellular space from damaged oligodendrocytes in multiple sclerosis lesions, where it undergoes transformation to the divalent ferrous form, further increasing ROS toxicity (Hametner et al., 2013).",
      "key": "b8d4b5c56996c0da746e5732487fdbf7",
      "line": 616,
      "relation": "directlyIncreases",
      "source": 1,
      "subject": {
        "location": {
          "name": "extracellular space",
          "namespace": "GO"
        }
      },
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "If axonal Na+ rises above its nominal concentration, the Na+ /Ca2+ exchanger, normally exchanging axoplasmic Ca2+ for extracellular Na+ , will operate in a reverse Ca2+ importing mode.",
      "key": "7df907be24e17fc8fd3e0046378d8b02",
      "line": 623,
      "object": {
        "location": {
          "name": "axon",
          "namespace": "GO"
        }
      },
      "relation": "directlyIncreases",
      "source": 6,
      "subject": {
        "location": {
          "name": "axon",
          "namespace": "GO"
        }
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "With increasing electrical traffic, axoplasmic Ca2+ will rise and eventually a Ca2+- mediated degenerative response will be initiated (Trapp and Stys, 2009).",
      "key": "47cb95e36dafbc82df1f62504d3504b7",
      "line": 632,
      "relation": "directlyIncreases",
      "source": 0,
      "subject": {
        "location": {
          "name": "axon",
          "namespace": "GO"
        }
      },
      "target": 157
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Excess of intra-axonal Ca2+ may stimulate a variety of Ca2+ dependent catabolic enzyme systems, including proteases, phospholipases and calpains, ultimately leading to progressive intra-axonal proteolytic degradation of cytoskeletal proteins and axonal degeneration (Stys, 2005).",
      "key": "e444c2113f1c5e399e44b529faaf7e34",
      "line": 637,
      "relation": "increases",
      "source": 0,
      "subject": {
        "location": {
          "name": "axon",
          "namespace": "GO"
        }
      },
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Excess of intra-axonal Ca2+ may stimulate a variety of Ca2+ dependent catabolic enzyme systems, including proteases, phospholipases and calpains, ultimately leading to progressive intra-axonal proteolytic degradation of cytoskeletal proteins and axonal degeneration (Stys, 2005).",
      "key": "c4f77b9a11beb78314d2e3dda028e196",
      "line": 638,
      "relation": "increases",
      "source": 0,
      "subject": {
        "location": {
          "name": "axon",
          "namespace": "GO"
        }
      },
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Moreover, intracellular Ca2+ increase results in changes in microtubules and neurofilament phosphorylation, ultimately causing cytoskeleton breakdown (Nicholls, 2004).",
      "key": "83b7b770da0b16eba3a227642c6ae03b",
      "line": 647,
      "relation": "negativeCorrelation",
      "source": 0,
      "subject": {
        "location": {
          "name": "axon",
          "namespace": "GO"
        }
      },
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Moreover, intracellular Ca2+ increase results in changes in microtubules and neurofilament phosphorylation, ultimately causing cytoskeleton breakdown (Nicholls, 2004).",
      "key": "1641046528b93dae10a42dfdb86c49da",
      "line": 648,
      "relation": "negativeCorrelation",
      "source": 0,
      "subject": {
        "location": {
          "name": "axon",
          "namespace": "GO"
        }
      },
      "target": 123
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "If axonal Na+ rises above its nominal concentration, the Na+ /Ca2+ exchanger, normally exchanging axoplasmic Ca2+ for extracellular Na+ , will operate in a reverse Ca2+ importing mode.",
      "key": "ebd11839607ec15bef7a8fdf0452d9b1",
      "line": 624,
      "object": {
        "location": {
          "name": "axon",
          "namespace": "GO"
        }
      },
      "relation": "directlyDecreases",
      "source": 126,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "If axonal Na+ rises above its nominal concentration, the Na+ /Ca2+ exchanger, normally exchanging axoplasmic Ca2+ for extracellular Na+ , will operate in a reverse Ca2+ importing mode.",
      "key": "ae280267c51c8736442a77ef90cdd342",
      "line": 626,
      "object": {
        "location": {
          "name": "extracellular space",
          "namespace": "GO"
        }
      },
      "relation": "directlyDecreases",
      "source": 126,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "If axonal Na+ rises above its nominal concentration, the Na+ /Ca2+ exchanger, normally exchanging axoplasmic Ca2+ for extracellular Na+ , will operate in a reverse Ca2+ importing mode.",
      "key": "7eb85242536975cc0a335a970a9d0fba",
      "line": 625,
      "object": {
        "location": {
          "name": "axon",
          "namespace": "GO"
        }
      },
      "relation": "directlyIncreases",
      "source": 126,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Excess of intra-axonal Ca2+ may stimulate a variety of Ca2+ dependent catabolic enzyme systems, including proteases, phospholipases and calpains, ultimately leading to progressive intra-axonal proteolytic degradation of cytoskeletal proteins and axonal degeneration (Stys, 2005).",
      "key": "c1f0d01447caef43f6914e8aaf31bcd1",
      "line": 639,
      "relation": "directlyIncreases",
      "source": 23,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Excess of intra-axonal Ca2+ may stimulate a variety of Ca2+ dependent catabolic enzyme systems, including proteases, phospholipases and calpains, ultimately leading to progressive intra-axonal proteolytic degradation of cytoskeletal proteins and axonal degeneration (Stys, 2005).",
      "key": "a8d86d8950128491617e06bd25a041a4",
      "line": 641,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "directlyIncreases",
      "source": 23,
      "target": 116
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Excess of intra-axonal Ca2+ may stimulate a variety of Ca2+ dependent catabolic enzyme systems, including proteases, phospholipases and calpains, ultimately leading to progressive intra-axonal proteolytic degradation of cytoskeletal proteins and axonal degeneration (Stys, 2005).",
      "key": "6f90c050d744e3339f93eb98a226eb50",
      "line": 640,
      "relation": "directlyIncreases",
      "source": 32,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Excess of intra-axonal Ca2+ may stimulate a variety of Ca2+ dependent catabolic enzyme systems, including proteases, phospholipases and calpains, ultimately leading to progressive intra-axonal proteolytic degradation of cytoskeletal proteins and axonal degeneration (Stys, 2005).",
      "key": "7cabce7fdb70e47dca31ab7ee3913815",
      "line": 642,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "directlyIncreases",
      "source": 32,
      "target": 116
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Moreover, intracellular Ca2+ increase results in changes in microtubules and neurofilament phosphorylation, ultimately causing cytoskeleton breakdown (Nicholls, 2004).",
      "key": "464e680521e03c255c9054705f340cbd",
      "line": 647,
      "object": {
        "location": {
          "name": "axon",
          "namespace": "GO"
        }
      },
      "relation": "negativeCorrelation",
      "source": 120,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Moreover, intracellular Ca2+ increase results in changes in microtubules and neurofilament phosphorylation, ultimately causing cytoskeleton breakdown (Nicholls, 2004).",
      "key": "b99f254094f7ca8c708b4edb38ae3b0a",
      "line": 649,
      "relation": "regulates",
      "source": 120,
      "target": 168
    },
    {
      "key": "c45272a9233a9dbce2d1f16106f59925",
      "relation": "hasVariant",
      "source": 119,
      "target": 120
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Moreover, intracellular Ca2+ increase results in changes in microtubules and neurofilament phosphorylation, ultimately causing cytoskeleton breakdown (Nicholls, 2004).",
      "key": "5e13216447aee08921c5461e99fa71af",
      "line": 648,
      "object": {
        "location": {
          "name": "axon",
          "namespace": "GO"
        }
      },
      "relation": "negativeCorrelation",
      "source": 123,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Moreover, intracellular Ca2+ increase results in changes in microtubules and neurofilament phosphorylation, ultimately causing cytoskeleton breakdown (Nicholls, 2004).",
      "key": "5037d895598bd4a240ec496bf5633a7f",
      "line": 650,
      "relation": "regulates",
      "source": 123,
      "target": 168
    },
    {
      "key": "9cbfe86a64512b901750790839d2bb3d",
      "relation": "hasVariant",
      "source": 122,
      "target": 123
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Axons that lack Na+ /K + ATPase cannot exchange axoplasmic Na+ for K+ and are incapable of repolarizing the axolemma.",
      "key": "d864472691f30520018ecc18542445a8",
      "line": 655,
      "relation": "regulates",
      "source": 127,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Redistribution of voltage-gated Ca2+ channels, transient potential receptor melastatin 4 (TRPM4), and acid-sensing ion channel1 (ASIC1) induce neuroaxonal Ca2+ overload, eliciting deleterious effects on axons (Friese et al., 2014).",
      "key": "162bb63ed5f16f9f84871e15742efbaa",
      "line": 661,
      "relation": "decreases",
      "source": 112,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Excitotoxicity is caused mainly by sustained activation of glutamate receptors and subsequent massive influx of Ca2+ into viable neurons.",
      "key": "fb8b5d79b7782a3948ad982d047cf24a",
      "line": 670,
      "relation": "increases",
      "source": 78,
      "target": 134
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Redistribution of voltage-gated Ca2+ channels, transient potential receptor melastatin 4 (TRPM4), and acid-sensing ion channel1 (ASIC1) induce neuroaxonal Ca2+ overload, eliciting deleterious effects on axons (Friese et al., 2014).",
      "key": "f79af532e966ea97c9aba2b5f2624a0b",
      "line": 662,
      "relation": "decreases",
      "source": 115,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Redistribution of voltage-gated Ca2+ channels, transient potential receptor melastatin 4 (TRPM4), and acid-sensing ion channel1 (ASIC1) induce neuroaxonal Ca2+ overload, eliciting deleterious effects on axons (Friese et al., 2014).",
      "key": "973bed6cc9380b6724c788d2e00a7a6b",
      "line": 663,
      "relation": "decreases",
      "source": 89,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Excitotoxicity is caused mainly by sustained activation of glutamate receptors and subsequent massive influx of Ca2+ into viable neurons.",
      "key": "08a12fb887c47e68111488722671a7f3",
      "line": 669,
      "relation": "increases",
      "source": 125,
      "subject": {
        "modifier": "Activity"
      },
      "target": 134
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system gray matter layer": true
        },
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Female": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Increased sex hormone levels in females may protect against grey matter atrophy (Cutter et al., 2006). In contrast, testosterone was shown to amplify oligodendrocyte excitotoxicity, potentially limiting remyelination (Caruso et al., 2004).",
      "key": "b7e783b385c876d34417d51c9a8200d1",
      "line": 695,
      "relation": "directlyDecreases",
      "source": 118,
      "target": 165
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Increased sex hormone levels in females may protect against grey matter atrophy (Cutter et al., 2006). In contrast, testosterone was shown to amplify oligodendrocyte excitotoxicity, potentially limiting remyelination (Caruso et al., 2004).",
      "key": "590684976f0d87a8ed90ecbf6ab07a44",
      "line": 698,
      "relation": "directlyIncreases",
      "source": 131,
      "target": 134
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Increased sex hormone levels in females may protect against grey matter atrophy (Cutter et al., 2006). In contrast, testosterone was shown to amplify oligodendrocyte excitotoxicity, potentially limiting remyelination (Caruso et al., 2004).",
      "key": "58411790c262372f301597b17a7ca13a",
      "line": 699,
      "relation": "decreases",
      "source": 131,
      "target": 176
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because NAA is detected almost exclusively in neurons and their processes, decreased levels of this metabolite have been interpreted as evidence of axonal injury.",
      "key": "37be79be5bee35f04541a34862193657",
      "line": 711,
      "relation": "association",
      "source": 53,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "The mitoxantrone in multiple sclerosis (MIMS) study was a double-blind phase II study of mitoxantrone in patients with SPMS with and without relapses (Hartung et al., 2002).",
      "key": "0301235aeb6f453f0eec87ea644c1c0f",
      "line": 730,
      "relation": "decreases",
      "source": 49,
      "target": 152
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Unfortunately, risk of serious side effects such as cardiomyopathy and treatment-related acute leukaemia has substantially limited indication in clinical practice (Goodin et al., 2003).",
      "key": "46bdcf1f97e048e4e55db62aa50e4195",
      "line": 735,
      "relation": "increases",
      "source": 49,
      "target": 167
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Unfortunately, risk of serious side effects such as cardiomyopathy and treatment-related acute leukaemia has substantially limited indication in clinical practice (Goodin et al., 2003).",
      "key": "38f9ce6ad8b722882a42cfd1a7fb1bda",
      "line": 736,
      "relation": "increases",
      "source": 49,
      "target": 150
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Several phase III clinical trials using IFNbeta1a and IFNbeta1b in SPMS did not show permanent disability delay, but did reduce relapses risk (SPECTRIMS Study Group, 2001; Cohen et al., 2002; Andersen et al., 2004; Panitch et al.,2004).",
      "key": "8cb47cfbd332d48db8422eb612ca1b96",
      "line": 741,
      "relation": "decreases",
      "source": 39,
      "target": 143
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Several phase III clinical trials using IFNbeta1a and IFNbeta1b in SPMS did not show permanent disability delay, but did reduce relapses risk (SPECTRIMS Study Group, 2001; Cohen et al., 2002; Andersen et al., 2004; Panitch et al.,2004).",
      "key": "92a81eb74db77d76bdc2d876761fddb9",
      "line": 743,
      "relation": "directlyDecreases",
      "source": 39,
      "target": 154
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Interestingly, some immunomodulatory agents used for multiple sclerosis, namely IFN-beta and glatiramer acetate have been shown to increase serum or immune cell levels of BDNF in patients with multiple sclerosis, suggested as a possible mechanism of action for these therapies (Kalinowska-Lyszczarz and Losy, 2012).",
      "key": "f23afa31f4444e7da00a3c1625dadae2",
      "line": 845,
      "relation": "increases",
      "source": 39,
      "target": 130
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Interestingly, some immunomodulatory agents used for multiple sclerosis, namely IFN-beta and glatiramer acetate have been shown to increase serum or immune cell levels of BDNF in patients with multiple sclerosis, suggested as a possible mechanism of action for these therapies (Kalinowska-Lyszczarz and Losy, 2012).",
      "key": "f99fe5c8d14b93625e1a605f8c6046ac",
      "line": 847,
      "relation": "increases",
      "source": 39,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Several phase III clinical trials using IFNbeta1a and IFNbeta1b in SPMS did not show permanent disability delay, but did reduce relapses risk (SPECTRIMS Study Group, 2001; Cohen et al., 2002; Andersen et al., 2004; Panitch et al.,2004).",
      "key": "ec5c4b2f35bc263073aeb2ee9aa5ec7b",
      "line": 742,
      "relation": "decreases",
      "source": 45,
      "target": 143
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Several phase III clinical trials using IFNbeta1a and IFNbeta1b in SPMS did not show permanent disability delay, but did reduce relapses risk (SPECTRIMS Study Group, 2001; Cohen et al., 2002; Andersen et al., 2004; Panitch et al.,2004).",
      "key": "1a968b62a3883623dda83966c9794c3c",
      "line": 744,
      "relation": "directlyDecreases",
      "source": 45,
      "target": 154
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Natalizumab did show some positive effects on upper limb function, but did not slow down disability accumulation compared to rates observed in the placebo group (NCT01416181).",
      "key": "53fb36e1eda542b38e5c78a5b98e8e88",
      "line": 750,
      "relation": "causesNoChange",
      "source": 35,
      "target": 143
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Ocrelizumab is a fully humanized monoclonal antibody that depletes B cells via antibody-dependent cell-mediated toxicity, more than complement-dependent cytotoxicity, which could reduce infusion-related toxic side effects (Buttmann, 2010).",
      "key": "cb1828e2850390ebeb6afae07c53fdba",
      "line": 755,
      "relation": "directlyIncreases",
      "source": 50,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Thus, ocrelizumab becomes the first agent to have shown positive results in pivotal studies in PPMS (NCT 1194570).",
      "key": "4770216ab2d8db88710383cee0034b50",
      "line": 761,
      "relation": "decreases",
      "source": 50,
      "target": 153
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Ocrelizumab is a fully humanized monoclonal antibody that depletes B cells via antibody-dependent cell-mediated toxicity, more than complement-dependent cytotoxicity, which could reduce infusion-related toxic side effects (Buttmann, 2010).",
      "key": "e68578f91b245afb88ac5e71a77f48b3",
      "line": 756,
      "relation": "decreases",
      "source": 57,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Recently, two studies reported protective properties of MitoQ, a specific inhibitor for mitochondrial ROS production, in EAE (Davies et al.,2013).",
      "key": "2a97e38dedc37668a745fc75f5ef961c",
      "line": 768,
      "object": {
        "location": {
          "name": "mitochondrion",
          "namespace": "GO"
        }
      },
      "relation": "directlyDecreases",
      "source": 34,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because levels of inflammation were not affected by MitoQ, it is conceivable that increased mitochondrial protection against ROS is sufficient to reduce axonal damage.",
      "key": "931cb8d53d64071f117698aa6cdb999c",
      "line": 774,
      "relation": "causesNoChange",
      "source": 34,
      "target": 171
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Because levels of inflammation were not affected by MitoQ, it is conceivable that increased mitochondrial protection against ROS is sufficient to reduce axonal damage.",
      "key": "38356ec0fb6ced10bc6a7e58adefc956",
      "line": 775,
      "relation": "directlyDecreases",
      "source": 34,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "The antioxidant idebenone was proven to be beneficial in Leber’s hereditary optic neuropathy, a disorder caused by mitochondrial defects.",
      "key": "59f1f1e174ac4226f4d5cd63c4022b11",
      "line": 780,
      "relation": "isA",
      "source": 47,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "The antioxidant idebenone was proven to be beneficial in Leber’s hereditary optic neuropathy, a disorder caused by mitochondrial defects.",
      "key": "a037955c0561f5a224fa7c4c8ef822b3",
      "line": 781,
      "relation": "directlyDecreases",
      "source": 47,
      "target": 159
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "However, in EAE, idebenone failed to affect disease incidence or onset when applied preventively, or to reduce disease severity when applied therapeutically.",
      "key": "ec594c04d92da24dfc45c41e1148fb68",
      "line": 788,
      "relation": "causesNoChange",
      "source": 47,
      "target": 146
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "The antioxidant idebenone was proven to be beneficial in Leber’s hereditary optic neuropathy, a disorder caused by mitochondrial defects.",
      "key": "0337adfb3436fc85f5f724b69291492e",
      "line": 782,
      "relation": "isA",
      "source": 159,
      "target": 151
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In EAE systemic administration of flecainamide (Bechtold et al., 2004), or Na+ channel-blocking anticonvulsants (lamotrigine, phenytoin, carbamazepine) (Bechtold et al., 2004, 2006) reduced neurological disability.",
      "key": "888aff98b3db6f4202435b50cf5ebcbe",
      "line": 796,
      "relation": "decreases",
      "source": 48,
      "target": 158
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "However, clinical trials of lamotrigine in patients with progressive multiple sclerosis did not show advantages over placebo with respect to neuroprotection (Hayton et al., 2012).",
      "key": "81c3857ad3a3b5380b145c1847264795",
      "line": 805,
      "relation": "causesNoChange",
      "source": 48,
      "target": 152
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In EAE systemic administration of flecainamide (Bechtold et al., 2004), or Na+ channel-blocking anticonvulsants (lamotrigine, phenytoin, carbamazepine) (Bechtold et al., 2004, 2006) reduced neurological disability.",
      "key": "1ba31547b1035fe4d1c0729861af717d",
      "line": 797,
      "relation": "decreases",
      "source": 37,
      "target": 158
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "In EAE systemic administration of flecainamide (Bechtold et al., 2004), or Na+ channel-blocking anticonvulsants (lamotrigine, phenytoin, carbamazepine) (Bechtold et al., 2004, 2006) reduced neurological disability.",
      "key": "790584cba0007062893c6094b9c8b7b3",
      "line": 798,
      "relation": "decreases",
      "source": 40,
      "target": 158
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",
      "key": "aa55269d3694405ea6dca96b7a52e064",
      "line": 812,
      "relation": "directlyDecreases",
      "source": 36,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",
      "key": "368dcda1cb35c41f29f98c01b364a82a",
      "line": 813,
      "relation": "directlyDecreases",
      "source": 36,
      "target": 112
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",
      "key": "a032118ce53560e9578747815fd0d966",
      "line": 816,
      "relation": "increases",
      "source": 36,
      "target": 173
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",
      "key": "93b2e9fe9a6b98d79fcbafd1a7d72832",
      "line": 818,
      "relation": "increases",
      "source": 36,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",
      "key": "6423edbf71811dc415cc6c50d7ce5b8f",
      "line": 820,
      "relation": "decreases",
      "source": 36,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",
      "key": "670b07e7c87bb8d620e0e15a700ac278",
      "line": 814,
      "relation": "directlyDecreases",
      "source": 44,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",
      "key": "d59e2d646e56dcc0882cdf9fa7b766ed",
      "line": 815,
      "relation": "directlyDecreases",
      "source": 44,
      "target": 112
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",
      "key": "31cb3c5801f95d5473ccc908ac60773f",
      "line": 817,
      "relation": "increases",
      "source": 44,
      "target": 173
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",
      "key": "b772509f8cd8943b6e5e9bf83ac77c10",
      "line": 819,
      "relation": "increases",
      "source": 44,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",
      "key": "7969c818a5fa10fdf2f6108b7e45f422",
      "line": 821,
      "relation": "decreases",
      "source": 44,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Treatment with the AMPA/kainate glutamate receptor NBQX decreased neurological disability, increased oligodendrocyte survival and reduced axonal damage in EAE (Pitt et al., 2000).",
      "key": "7f6c1b1372367ab7449709f78c6c92eb",
      "line": 826,
      "relation": "decreases",
      "source": 43,
      "target": 155
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Treatment with the AMPA/kainate glutamate receptor NBQX decreased neurological disability, increased oligodendrocyte survival and reduced axonal damage in EAE (Pitt et al., 2000).",
      "key": "81156a112c31b2280730cae6c766ab37",
      "line": 827,
      "relation": "increases",
      "source": 43,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Treatment with the AMPA/kainate glutamate receptor NBQX decreased neurological disability, increased oligodendrocyte survival and reduced axonal damage in EAE (Pitt et al., 2000).",
      "key": "5ffb3079273568a7e4d8e0a5cf459522",
      "line": 828,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 43,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "GDNF (glial-cell-line derived neurotrophic factor), IGF1, and BDNF are implicated in trophic support provided for axons by oligodendrocytes (Wilkins et al., 2003), which one would predict would be deficient in multiple sclerosis.",
      "key": "871d10a09ab6bf7124b9396b0d504294",
      "line": 837,
      "relation": "association",
      "source": 97,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "GDNF (glial-cell-line derived neurotrophic factor), IGF1, and BDNF are implicated in trophic support provided for axons by oligodendrocytes (Wilkins et al., 2003), which one would predict would be deficient in multiple sclerosis.",
      "key": "0a90cca86e505c8acc695d64d0a21a48",
      "line": 838,
      "relation": "association",
      "source": 101,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "GDNF (glial-cell-line derived neurotrophic factor), IGF1, and BDNF are implicated in trophic support provided for axons by oligodendrocytes (Wilkins et al., 2003), which one would predict would be deficient in multiple sclerosis.",
      "key": "0bf1a981b369d46343bc75339d32bf69",
      "line": 839,
      "relation": "association",
      "source": 92,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "GDNF (glial-cell-line derived neurotrophic factor), IGF1, and BDNF are implicated in trophic support provided for axons by oligodendrocytes (Wilkins et al., 2003), which one would predict would be deficient in multiple sclerosis.",
      "key": "3c63bcc10e8d43234062ffa9ee8e1e87",
      "line": 837,
      "relation": "association",
      "source": 59,
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "GDNF (glial-cell-line derived neurotrophic factor), IGF1, and BDNF are implicated in trophic support provided for axons by oligodendrocytes (Wilkins et al., 2003), which one would predict would be deficient in multiple sclerosis.",
      "key": "a15f4962949521809873842913cd0c3f",
      "line": 838,
      "relation": "association",
      "source": 59,
      "target": 101
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "GDNF (glial-cell-line derived neurotrophic factor), IGF1, and BDNF are implicated in trophic support provided for axons by oligodendrocytes (Wilkins et al., 2003), which one would predict would be deficient in multiple sclerosis.",
      "key": "c61b4f5e0fc0e630640b1ef591c49602",
      "line": 839,
      "relation": "association",
      "source": 59,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Interestingly, some immunomodulatory agents used for multiple sclerosis, namely IFN-beta and glatiramer acetate have been shown to increase serum or immune cell levels of BDNF in patients with multiple sclerosis, suggested as a possible mechanism of action for these therapies (Kalinowska-Lyszczarz and Losy, 2012).",
      "key": "7c70de7456c04c13ac49022d583ab2c9",
      "line": 846,
      "relation": "increases",
      "source": 41,
      "target": 130
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Interestingly, some immunomodulatory agents used for multiple sclerosis, namely IFN-beta and glatiramer acetate have been shown to increase serum or immune cell levels of BDNF in patients with multiple sclerosis, suggested as a possible mechanism of action for these therapies (Kalinowska-Lyszczarz and Losy, 2012).",
      "key": "2fef40e1e5ddc09a7c30e4757a23a5d5",
      "line": 848,
      "relation": "increases",
      "source": 41,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Also laquinimod has neuroprotective potential that may depend, at least in part, on its effects on astrocytes and microglia (Bruck et al., 2012; Mishra et al., 2014).",
      "key": "8f7df491727608f6610de71b720b51e0",
      "line": 854,
      "relation": "isA",
      "source": 51,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Also laquinimod has neuroprotective potential that may depend, at least in part, on its effects on astrocytes and microglia (Bruck et al., 2012; Mishra et al., 2014).",
      "key": "402d86f7a310dc6c54bdbc399d77ce5e",
      "line": 855,
      "relation": "association",
      "source": 51,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Also laquinimod has neuroprotective potential that may depend, at least in part, on its effects on astrocytes and microglia (Bruck et al., 2012; Mishra et al., 2014).",
      "key": "a55b3102dc0f93be2e4f12e3ca0cc5a8",
      "line": 856,
      "relation": "association",
      "source": 51,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "MN-166 (ibudilast) is a non-selective phosphodiesterase inhibitor that suppresses pro-inflammatory cytokines, promotes neurotrophic factors, and attenuates activated glial cell (Suzumura et al., 2003; Feng et al., 2004).",
      "key": "c506a28228eae36b43c86cacb04fda6f",
      "line": 861,
      "relation": "directlyIncreases",
      "source": 46,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "MN-166 (ibudilast) is a non-selective phosphodiesterase inhibitor that suppresses pro-inflammatory cytokines, promotes neurotrophic factors, and attenuates activated glial cell (Suzumura et al., 2003; Feng et al., 2004).",
      "key": "11916470674f781a581e980e85cf159c",
      "line": 862,
      "relation": "directlyDecreases",
      "source": 46,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It is known that DMF reduces oxidative stress related to neuronal death and myelin damage, via the Nrf2 pathway, making DMF a potential therapeutic option for progressive multiple sclerosis (Strassburger- Krogias et al., 2014).",
      "key": "ee58f1883d937c14a2f121980d284055",
      "line": 869,
      "relation": "increases",
      "source": 52,
      "target": 108
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It is known that DMF reduces oxidative stress related to neuronal death and myelin damage, via the Nrf2 pathway, making DMF a potential therapeutic option for progressive multiple sclerosis (Strassburger- Krogias et al., 2014).",
      "key": "677b1215e548b9c418da7494b2459e21",
      "line": 870,
      "relation": "decreases",
      "source": 108,
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "It is known that DMF reduces oxidative stress related to neuronal death and myelin damage, via the Nrf2 pathway, making DMF a potential therapeutic option for progressive multiple sclerosis (Strassburger- Krogias et al., 2014).",
      "key": "e18027af1779bd6ba07a52db9d3a0653",
      "line": 872,
      "relation": "negativeCorrelation",
      "source": 73,
      "target": 160
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Masitinib is a selective tyrosine kinase inhibitor controlling mast cell degranulation, NO-mediated damage, and dendritic cell activity (Dubreuil et al., 2009).",
      "key": "395fb5f5c04cfba6125223f9b7d2b5fb",
      "line": 877,
      "relation": "directlyDecreases",
      "source": 33,
      "target": 124
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Masitinib is a selective tyrosine kinase inhibitor controlling mast cell degranulation, NO-mediated damage, and dendritic cell activity (Dubreuil et al., 2009).",
      "key": "439328b5c47c57aa47bf26bee887c7dc",
      "line": 878,
      "relation": "regulates",
      "source": 33,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Masitinib is a selective tyrosine kinase inhibitor controlling mast cell degranulation, NO-mediated damage, and dendritic cell activity (Dubreuil et al., 2009).",
      "key": "722e5a63444b73f7781abfb601453276",
      "line": 879,
      "relation": "regulates",
      "source": 33,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "Masitinib is a selective tyrosine kinase inhibitor controlling mast cell degranulation, NO-mediated damage, and dendritic cell activity (Dubreuil et al., 2009).",
      "key": "ac30a7b91f3d5d28cd36f5711298cd52",
      "line": 880,
      "relation": "regulates",
      "source": 33,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "LINGO1, a CNS-specific membrane glycoprotein that suppresses oligodendrocyte differentiation and myelination, is possibly involved in failure of remyelination and axonal repair in multiple sclerosis (Yong, 2009); blockade of this protein may therefore be effective in promoting remyelination in a clinical setting.",
      "key": "15004e27654a0e598777c114466bab30",
      "line": 887,
      "relation": "directlyDecreases",
      "source": 106,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "LINGO1, a CNS-specific membrane glycoprotein that suppresses oligodendrocyte differentiation and myelination, is possibly involved in failure of remyelination and axonal repair in multiple sclerosis (Yong, 2009); blockade of this protein may therefore be effective in promoting remyelination in a clinical setting.",
      "key": "ddf62295c7bd4659797f520c71abc795",
      "line": 888,
      "relation": "directlyDecreases",
      "source": 106,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "LINGO1, a CNS-specific membrane glycoprotein that suppresses oligodendrocyte differentiation and myelination, is possibly involved in failure of remyelination and axonal repair in multiple sclerosis (Yong, 2009); blockade of this protein may therefore be effective in promoting remyelination in a clinical setting.",
      "key": "307b9d62a226fcd4142119ad8c0235a0",
      "line": 889,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 152
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Correale J",
          "Fiol MP",
          "Gaitán MI",
          "Ysrraelit MC"
        ],
        "date": "2017-03-01",
        "db": "PubMed",
        "db_id": "27794524",
        "db_name": "Progressive multiple sclerosis: from pathogenic mechanisms to treatment.",
        "first": "Correale J",
        "journal": "Brain : a journal of neurology",
        "last": "Fiol MP",
        "pages": "527-546",
        "volume": "140"
      },
      "evidence": "BIIB033, a fully human monoclonal antibody that selectively antagonizes LINGO1, was found to be safe and well-tolerated in phase 1 studies (Tran et al., 2014).",
      "key": "187f47ca4cd5b38cb5bdf02ffa7f7aca",
      "line": 896,
      "relation": "directlyDecreases",
      "source": 42,
      "target": 106
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"calcium(2+)\")",
      "concept": {
        "name": "calcium(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "94df77a2db8d9014b42535235da90e5d"
    },
    {
      "bel": "a(CHEBI:\"iron(2+)\")",
      "concept": {
        "name": "iron(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "be7ed197cc239803fafad58c7dc415ba"
    },
    {
      "bel": "a(CHEBI:\"iron(3+)\")",
      "concept": {
        "name": "iron(3+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e36ee1745bb990bf5c32f9db20b3af67"
    },
    {
      "bel": "a(CHEBI:\"nitric oxide\")",
      "concept": {
        "name": "nitric oxide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "da5a3d810aacb9c4649ec7df3b5f60d3"
    },
    {
      "bel": "a(CHEBI:\"reactive nitrogen species\")",
      "concept": {
        "name": "reactive nitrogen species",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "956fe20ef57afe781af9bcddfb66c2f2"
    },
    {
      "bel": "a(CHEBI:\"reactive oxygen species\")",
      "concept": {
        "name": "reactive oxygen species",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "39a67bec2ea8cb7a2bec39cf66e565ba"
    },
    {
      "bel": "a(CHEBI:\"sodium(1+)\")",
      "concept": {
        "name": "sodium(1+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "378a388d69fb9f413ff852bcad3fea66"
    },
    {
      "bel": "a(CHEBI:laquinimod)",
      "concept": {
        "name": "laquinimod",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "4cc41943782eab603c293417677211aa"
    },
    {
      "bel": "a(MESH:\"Anti-Inflammatory Agents\")",
      "concept": {
        "name": "Anti-Inflammatory Agents",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "a9cf39befdc22d33b63e3f87327f3b50"
    },
    {
      "bel": "a(MESH:\"B-Cell Maturation Antigen\")",
      "concept": {
        "name": "B-Cell Maturation Antigen",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "4a9dc2ecb86783b8bc9b33cb1e0ec97d"
    },
    {
      "bel": "a(MESH:\"B-Lymphocytes\")",
      "concept": {
        "name": "B-Lymphocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f58463c9771eaea79cce530465284035"
    },
    {
      "bel": "a(MESH:\"CD8-Positive T-Lymphocytes\")",
      "concept": {
        "name": "CD8-Positive T-Lymphocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "59b2f285d4c75c8c59127aa7c441658c"
    },
    {
      "bel": "a(MESH:\"Dendritic Cells, Follicular\")",
      "concept": {
        "name": "Dendritic Cells, Follicular",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "217e76555be126a94392f259fc925dbd"
    },
    {
      "bel": "a(MESH:\"Free Radical Scavengers\")",
      "concept": {
        "name": "Free Radical Scavengers",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "d7a349bc866e54c65f29d2d1c77e2273"
    },
    {
      "bel": "a(MESH:\"Growth Differentiation Factors\")",
      "concept": {
        "name": "Growth Differentiation Factors",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "326fb12ea1e00d85b4778bf1e22f24b6"
    },
    {
      "bel": "a(MESH:\"Nerve Growth Factors\")",
      "concept": {
        "name": "Nerve Growth Factors",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "d912aa029e076216b470ad3d2e515136"
    },
    {
      "bel": "a(MESH:\"Neuroprotective Agents\")",
      "concept": {
        "name": "Neuroprotective Agents",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "445c820ea78a2bfb78495412f701ab5b"
    },
    {
      "bel": "a(MESH:\"Plasma Cells\")",
      "concept": {
        "name": "Plasma Cells",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "976bf10c4cc8f617d3e0c46987664e6a"
    },
    {
      "bel": "a(MESH:\"T-Lymphocytes, Cytotoxic\")",
      "concept": {
        "name": "T-Lymphocytes, Cytotoxic",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "57d8711b0db2cb722db07f5b2c07396c"
    },
    {
      "bel": "a(MESH:\"T-Lymphocytes, Helper-Inducer\")",
      "concept": {
        "name": "T-Lymphocytes, Helper-Inducer",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "addf362153ff7858e2d94b231c02e9b9"
    },
    {
      "bel": "a(MESH:Antioxidants)",
      "concept": {
        "name": "Antioxidants",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "e2c50eee7e534de741c350d07d7ec23e"
    },
    {
      "bel": "a(MESH:Astrocytes)",
      "concept": {
        "name": "Astrocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f02fc0f5c8a1ab66a9a7d9130d56d6fe"
    },
    {
      "bel": "a(MESH:Axons)",
      "concept": {
        "name": "Axons",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "438b15a6e68338bcf5615b067cf5d271"
    },
    {
      "bel": "a(MESH:Calpain)",
      "concept": {
        "name": "Calpain",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "115a7ef41b068b51af6bb41505461487"
    },
    {
      "bel": "a(MESH:Caspases)",
      "concept": {
        "name": "Caspases",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "d1830cc6f1ff92cbc7fda76399bfc02c"
    },
    {
      "bel": "a(MESH:Cytokines)",
      "concept": {
        "name": "Cytokines",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "0d3c01297f25a34285f54b350178a231"
    },
    {
      "bel": "a(MESH:Cytotoxins)",
      "concept": {
        "name": "Cytotoxins",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "0b6f56ff60f50d4fb9b3d66f8d194c5f"
    },
    {
      "bel": "a(MESH:Macrophages)",
      "concept": {
        "name": "Macrophages",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "311e39dad42597c983d7962f84ee92b6"
    },
    {
      "bel": "a(MESH:Microglia)",
      "concept": {
        "name": "Microglia",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "4ef490b325b2b1e33e41b4e22e1bd8c6"
    },
    {
      "bel": "a(MESH:Neurotoxins)",
      "concept": {
        "name": "Neurotoxins",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "3ef149871e4348e0397e85839cd3c807"
    },
    {
      "bel": "a(MESH:Oligodendroglia)",
      "concept": {
        "name": "Oligodendroglia",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "828404c8a29719c3b6437908364a6ddd"
    },
    {
      "bel": "a(MESH:Phagocytes)",
      "concept": {
        "name": "Phagocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "bf1fe3517e6fc85a24ce09919a1811c4"
    },
    {
      "bel": "a(MESH:Phospholipases)",
      "concept": {
        "name": "Phospholipases",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "421a18393d2bd64bcab42d502254f5bc"
    },
    {
      "bel": "a(PUBCHEM:10074640)",
      "concept": {
        "name": "10074640",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "0c717a6781463ab434d4c167c1d26331"
    },
    {
      "bel": "a(PUBCHEM:11388331)",
      "concept": {
        "name": "11388331",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "19ad3fa663f0254d1d382e01d53d692b"
    },
    {
      "bel": "a(PUBCHEM:135314782)",
      "concept": {
        "name": "135314782",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "e6cb2faf400c0ee34f5d8166513bf9de"
    },
    {
      "bel": "a(PUBCHEM:16231)",
      "concept": {
        "name": "16231",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "1b5ab22c6de486fa370608414fbc7fe8"
    },
    {
      "bel": "a(PUBCHEM:1775)",
      "concept": {
        "name": "1775",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "b3aeeb181e737b39fb1dbe25450a70a4"
    },
    {
      "bel": "a(PUBCHEM:20057304)",
      "concept": {
        "name": "20057304",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "136dcc500275636656ea1229b1c085c6"
    },
    {
      "bel": "a(PUBCHEM:223370366)",
      "concept": {
        "name": "223370366",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "ca8978b5ac7e24b5bfe27b2fc0ab361a"
    },
    {
      "bel": "a(PUBCHEM:2554)",
      "concept": {
        "name": "2554",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "5e9a571bda88739a4ab8423a4b8504e4"
    },
    {
      "bel": "a(PUBCHEM:3081884)",
      "concept": {
        "name": "3081884",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "ddbe69bd82a4c59996825ee33db337c8"
    },
    {
      "bel": "a(PUBCHEM:310264704)",
      "concept": {
        "name": "310264704",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "3e7a1b10290d3f9264957fcd0b2d0a1c"
    },
    {
      "bel": "a(PUBCHEM:3272524)",
      "concept": {
        "name": "3272524",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "a81d307e07c99dcd756d18b8a1e073d3"
    },
    {
      "bel": "a(PUBCHEM:3488)",
      "concept": {
        "name": "3488",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "b5bfbca019b596f9ebd1f754450ec5ac"
    },
    {
      "bel": "a(PUBCHEM:363907627)",
      "concept": {
        "name": "363907627",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "bdde073607ef19d75e028d3a46a7186a"
    },
    {
      "bel": "a(PUBCHEM:3671)",
      "concept": {
        "name": "3671",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "26476cf2fff1a5592414f46638a8dec8"
    },
    {
      "bel": "a(PUBCHEM:3686)",
      "concept": {
        "name": "3686",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "2b773e60e68dd8c618f5b8e9a62aeb76"
    },
    {
      "bel": "a(PUBCHEM:3878)",
      "concept": {
        "name": "3878",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "0f8670fb2e068a0ceb095190880ac7a7"
    },
    {
      "bel": "a(PUBCHEM:4212)",
      "concept": {
        "name": "4212",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "f31775e4a613bb4b82c90aaf7e04a572"
    },
    {
      "bel": "a(PUBCHEM:47206937)",
      "concept": {
        "name": "47206937",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "3852b69c25ba778b38510618a998137d"
    },
    {
      "bel": "a(PUBCHEM:54677946)",
      "concept": {
        "name": "54677946",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "4db44e621a4162e176984e01f116b539"
    },
    {
      "bel": "a(PUBCHEM:637568)",
      "concept": {
        "name": "637568",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "cfb6e2041ec338daa24a91a45673cf19"
    },
    {
      "bel": "a(PUBCHEM:65065)",
      "concept": {
        "name": "65065",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "2b674801b78aeb611dacaf9fb3978478"
    },
    {
      "bel": "bp(GO:\"B cell selection\")",
      "concept": {
        "name": "B cell selection",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "63092d0e9e5b8346496ce757fa62634d"
    },
    {
      "bel": "bp(GO:\"CD8-positive, alpha-beta T cell differentiation involved in immune response\")",
      "concept": {
        "name": "CD8-positive, alpha-beta T cell differentiation involved in immune response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "1e7f4e5dffe6b4b195d46f66114e0c70"
    },
    {
      "bel": "bp(GO:\"activation of innate immune response\")",
      "concept": {
        "name": "activation of innate immune response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d3f5a6366977e2c3eb99648eed624f6f"
    },
    {
      "bel": "bp(GO:\"antibody-dependent cellular cytotoxicity\")",
      "concept": {
        "name": "antibody-dependent cellular cytotoxicity",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "1dd3907cb6211aa938e6d8019a3c698d"
    },
    {
      "bel": "bp(GO:\"astrocyte activation\")",
      "concept": {
        "name": "astrocyte activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "025532507b2153e08f4ec37fe2da560c"
    },
    {
      "bel": "bp(GO:\"axon development\")",
      "concept": {
        "name": "axon development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "cb264ad706c25d23fedde395dca1ca2f"
    },
    {
      "bel": "bp(GO:\"brain development\")",
      "concept": {
        "name": "brain development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ac0c7c6bcd68b7fc8d43fa1e094e68f6"
    },
    {
      "bel": "bp(GO:\"calcium ion import\")",
      "concept": {
        "name": "calcium ion import",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "590d29036363f4ebfd72792a4934582a"
    },
    {
      "bel": "bp(GO:\"cell death\")",
      "concept": {
        "name": "cell death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "07a2f2734c3682bcb47105485c15b346"
    },
    {
      "bel": "bp(GO:\"central nervous system development\")",
      "concept": {
        "name": "central nervous system development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "7e4762f396be03c27440217d4b8ab6dc"
    },
    {
      "bel": "bp(GO:\"compartment boundary maintenance\")",
      "concept": {
        "name": "compartment boundary maintenance",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "65a0388599c266e74b55ab35d88b6bdc"
    },
    {
      "bel": "bp(GO:\"dendritic cell homeostasis\")",
      "concept": {
        "name": "dendritic cell homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c1571db44f88b28a8a6ae144555a2c87"
    },
    {
      "bel": "bp(GO:\"glial cell activation\")",
      "concept": {
        "name": "glial cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "4d32d1d54cdea811eb45d1daa3d71a5a"
    },
    {
      "bel": "bp(GO:\"glutamate homeostasis\")",
      "concept": {
        "name": "glutamate homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "094cdde3654b4e55daed8ea278e68fb7"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "concept": {
        "name": "inflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "abd32f6c5cca606061975532840db260"
    },
    {
      "bel": "bp(GO:\"mast cell degranulation\")",
      "concept": {
        "name": "mast cell degranulation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d26f6260157121aea3b7b8bd4451a596"
    },
    {
      "bel": "bp(GO:\"membrane repolarization\")",
      "concept": {
        "name": "membrane repolarization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "436cf60103b4992f531a1bf8ba08c324"
    },
    {
      "bel": "bp(GO:\"microglial cell activation\")",
      "concept": {
        "name": "microglial cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3c02f523866973a040dc6bfa5b372b2e"
    },
    {
      "bel": "bp(GO:\"monocyte migration into blood stream\")",
      "concept": {
        "name": "monocyte migration into blood stream",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b183c664caf4b43ffc3fea42c60419f9"
    },
    {
      "bel": "bp(GO:\"myelin maintenance\")",
      "concept": {
        "name": "myelin maintenance",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "0bd16b226ece454651f168af6ba594a6"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:\"neuron remodeling\")",
      "concept": {
        "name": "neuron remodeling",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "69ed037200b19011782f87305795d527"
    },
    {
      "bel": "bp(GO:\"nitric oxide mediated signal transduction\")",
      "concept": {
        "name": "nitric oxide mediated signal transduction",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "1316599db9e5833232ad1ac5c7f04803"
    },
    {
      "bel": "bp(GO:\"oligodendrocyte differentiation\")",
      "concept": {
        "name": "oligodendrocyte differentiation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "12a55344b9cf1428f955054862b1629e"
    },
    {
      "bel": "bp(GO:\"positive regulation of calcium ion import\")",
      "concept": {
        "name": "positive regulation of calcium ion import",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "bc0826269fe753fdb52d25e3cd45d5af"
    },
    {
      "bel": "bp(GO:\"regulation of B cell chemotaxis\")",
      "concept": {
        "name": "regulation of B cell chemotaxis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "8ccdecdaca8198df400c59e7bd5709f8"
    },
    {
      "bel": "bp(GO:\"regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II\")",
      "concept": {
        "name": "regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b0847f64e83ae3f71349ed9305f47dc2"
    },
    {
      "bel": "bp(GO:\"sodium ion import across plasma membrane\")",
      "concept": {
        "name": "sodium ion import across plasma membrane",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "cbe6273c4f709a9d99e482b3907000f6"
    },
    {
      "bel": "bp(GO:\"spinal cord development\")",
      "concept": {
        "name": "spinal cord development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "695ccaf88d8f9cb2b39eb99bd6e9bf9c"
    },
    {
      "bel": "bp(GO:myelination)",
      "concept": {
        "name": "myelination",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "484ae6456551d888476839afe30f4dcf"
    },
    {
      "bel": "complex(p(HGNC:EBI3), p(HGNC:IL12A))",
      "function": "Complex",
      "id": "dc80f5c7b90e7501b446bbe4b957b800",
      "members": [
        {
          "bel": "p(HGNC:EBI3)",
          "concept": {
            "name": "EBI3",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "6e2c2fbc3bc8c6e1daae86366eb3f4f4"
        },
        {
          "bel": "p(HGNC:IL12A)",
          "concept": {
            "name": "IL12A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "1e1573f4a37206d19b8eb6259a87f6b3"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:IFNG), p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor AMPA type subunits\"))",
      "function": "Complex",
      "id": "01454bf032a3e508e5d2021144837416",
      "members": [
        {
          "bel": "p(HGNC:IFNG)",
          "concept": {
            "name": "IFNG",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "20367a6ea54ae1032be4f48276f3c524"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor AMPA type subunits\")",
          "concept": {
            "name": "Glutamate ionotropic receptor AMPA type subunits",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "2b014fdb0e42ce7d4f844ac1d4fe4f83"
        }
      ]
    },
    {
      "bel": "composite(a(MESH:\"T-Lymphocytes, Cytotoxic\"), p(HGNC:FAS))",
      "function": "Composite",
      "id": "8710d8c696885f1638664dd0ea12b332",
      "members": [
        {
          "bel": "a(MESH:\"T-Lymphocytes, Cytotoxic\")",
          "concept": {
            "name": "T-Lymphocytes, Cytotoxic",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "57d8711b0db2cb722db07f5b2c07396c"
        },
        {
          "bel": "p(HGNC:FAS)",
          "concept": {
            "name": "FAS",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "b30b42f3905fc1cafbb9ec967ef6579a"
        }
      ]
    },
    {
      "bel": "g(HGNC:CCL2)",
      "concept": {
        "name": "CCL2",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "b76a68a0ef39e4d5481b339328daa82a"
    },
    {
      "bel": "g(HGNC:CSF2)",
      "concept": {
        "name": "CSF2",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "05ac042162f4007ccc694467fe56e633"
    },
    {
      "bel": "p(HGNC:ASIC1)",
      "concept": {
        "name": "ASIC1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "16a15671bf7cdaa6690694a975772a8e"
    },
    {
      "bel": "p(HGNC:B4GALT5)",
      "concept": {
        "name": "B4GALT5",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "70effc2e5f4081ec40b5892e9ef63aed"
    },
    {
      "bel": "p(HGNC:B4GALT6)",
      "concept": {
        "name": "B4GALT6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d5b73850c78ed44d95931afa7b45a46a"
    },
    {
      "bel": "p(HGNC:BDNF)",
      "concept": {
        "name": "BDNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a638d5f84b9678f17c8795852300134a"
    },
    {
      "bel": "p(HGNC:CXCL13)",
      "concept": {
        "name": "CXCL13",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1b59e29a03b8991322b5a74908338d9b"
    },
    {
      "bel": "p(HGNC:EBI3)",
      "concept": {
        "name": "EBI3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6e2c2fbc3bc8c6e1daae86366eb3f4f4"
    },
    {
      "bel": "p(HGNC:FAS)",
      "concept": {
        "name": "FAS",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b30b42f3905fc1cafbb9ec967ef6579a"
    },
    {
      "bel": "p(HGNC:FASLG)",
      "concept": {
        "name": "FASLG",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ec3bf523b9fdcef692bb9ac99f3eb376"
    },
    {
      "bel": "p(HGNC:GDNF)",
      "concept": {
        "name": "GDNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ef48c3c9bc7219f2da10e2a281284c22"
    },
    {
      "bel": "p(HGNC:GZMA)",
      "concept": {
        "name": "GZMA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "59bfb4798a3dfef7aa8c3080abebf445"
    },
    {
      "bel": "p(HGNC:GZMB)",
      "concept": {
        "name": "GZMB",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "985f77c9f0b080f89299aa9a7f3d816a"
    },
    {
      "bel": "p(HGNC:IFNG)",
      "concept": {
        "name": "IFNG",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "20367a6ea54ae1032be4f48276f3c524"
    },
    {
      "bel": "p(HGNC:IGF1)",
      "concept": {
        "name": "IGF1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4089131c84500a626f3306507fbf4b11"
    },
    {
      "bel": "p(HGNC:IL10)",
      "concept": {
        "name": "IL10",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e0c41f4b3cb8bef32af4e3217ba8aa12"
    },
    {
      "bel": "p(HGNC:IL12A)",
      "concept": {
        "name": "IL12A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1e1573f4a37206d19b8eb6259a87f6b3"
    },
    {
      "bel": "p(HGNC:IL1A)",
      "concept": {
        "name": "IL1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "017f14e3a15a95b856bdaba5630dcf34"
    },
    {
      "bel": "p(HGNC:IL6)",
      "concept": {
        "name": "IL6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8a1d3c4828c5416eba867c395cc65caa"
    },
    {
      "bel": "p(HGNC:LINGO1)",
      "concept": {
        "name": "LINGO1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5293ae73db034f03a25a047ae2a76e4c"
    },
    {
      "bel": "p(HGNC:LTA)",
      "concept": {
        "name": "LTA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "32cff1b69255f223f07827b246858919"
    },
    {
      "bel": "p(HGNC:NFE2L2)",
      "concept": {
        "name": "NFE2L2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7e8941fff5d3be67079854e55d40d075"
    },
    {
      "bel": "p(HGNC:PRF1)",
      "concept": {
        "name": "PRF1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bc1b85258241cfef60d62d56a2cf6306"
    },
    {
      "bel": "p(HGNC:TNF)",
      "concept": {
        "name": "TNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fdc1c1f5a73c3c992b6eb71ce9b6908e"
    },
    {
      "bel": "p(HGNC:TNFRSF1A)",
      "concept": {
        "name": "TNFRSF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "eba6462fb630d4db520fd03c20e60de0"
    },
    {
      "bel": "p(HGNC:TRPM4)",
      "concept": {
        "name": "TRPM4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6685d9fe52eb9b85f061177cda7f1c31"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor AMPA type subunits\")",
      "concept": {
        "name": "Glutamate ionotropic receptor AMPA type subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "2b014fdb0e42ce7d4f844ac1d4fe4f83"
    },
    {
      "bel": "p(MESH:\"B-Lymphocytes\")",
      "concept": {
        "name": "B-Lymphocytes",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "b17f0960fbbe2b68f3efc0b73dd96d1b"
    },
    {
      "bel": "p(MESH:\"Calcium Channels\")",
      "concept": {
        "name": "Calcium Channels",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "7bb4be60097b8a5772518c117fe8d0e3"
    },
    {
      "bel": "p(MESH:\"Cytoskeletal Proteins\")",
      "concept": {
        "name": "Cytoskeletal Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "4216907a1a5ceb766d3c2c78c1dd3b69"
    },
    {
      "bel": "p(MESH:\"Electron Transport Chain Complex Proteins\")",
      "concept": {
        "name": "Electron Transport Chain Complex Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "b5c741b9a6c242350e21f0d8dc7c0c19"
    },
    {
      "bel": "p(MESH:\"Gonadal Steroid Hormones\")",
      "concept": {
        "name": "Gonadal Steroid Hormones",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "74fddba1fe7175848dca6937d45a15b1"
    },
    {
      "bel": "p(MESH:\"Microtubule Proteins\")",
      "concept": {
        "name": "Microtubule Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "eb89e140393e32d32dad10c8a6f0b34a"
    },
    {
      "bel": "p(MESH:\"Microtubule Proteins\", pmod(Ph))",
      "concept": {
        "name": "Microtubule Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "ee28b2add255e1ec695f7c56777e4d4d",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MESH:\"Molecular Motor Proteins\")",
      "concept": {
        "name": "Molecular Motor Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "093ddfe98969ba7c965849f5051e4be7"
    },
    {
      "bel": "p(MESH:\"Neurofilament Proteins\")",
      "concept": {
        "name": "Neurofilament Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "a2e714494e6b0c8bf6dcfaaee8599d70"
    },
    {
      "bel": "p(MESH:\"Neurofilament Proteins\", pmod(Ph))",
      "concept": {
        "name": "Neurofilament Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "33a8be3eef0c74a07a67c212d6380f4f",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MESH:\"Receptor Protein-Tyrosine Kinases\")",
      "concept": {
        "name": "Receptor Protein-Tyrosine Kinases",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "af8ae4021d5956d672917161799c43e6"
    },
    {
      "bel": "p(MESH:\"Receptors, Glutamate\")",
      "concept": {
        "name": "Receptors, Glutamate",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "74a517b281e9cbdce458c53907a9f6b6"
    },
    {
      "bel": "p(MESH:\"Sodium-Calcium Exchanger\")",
      "concept": {
        "name": "Sodium-Calcium Exchanger",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "34b7b8e6e01ecbc80f57cfbe123a4fbc"
    },
    {
      "bel": "p(MESH:\"Sodium-Potassium-Exchanging ATPase\")",
      "concept": {
        "name": "Sodium-Potassium-Exchanging ATPase",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "451c52efd6656548160cb818c4ce4929"
    },
    {
      "bel": "p(MESH:\"T-Lymphocytes\")",
      "concept": {
        "name": "T-Lymphocytes",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "ca2b3f32a853b4b34f0f5db4956d5f50"
    },
    {
      "bel": "p(MESH:Mitochondria)",
      "concept": {
        "name": "Mitochondria",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "4b58f4362369631169a5a25793afce04"
    },
    {
      "bel": "p(MESH:Serum)",
      "concept": {
        "name": "Serum",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "17f76f8ca06d59212ee1dbad2bbb7a71"
    },
    {
      "bel": "p(MESH:Testosterone)",
      "concept": {
        "name": "Testosterone",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "3ebd79a260b5a0c08b142d79f6115c97"
    },
    {
      "bel": "p(NCBIGENE:7707)",
      "concept": {
        "name": "7707",
        "namespace": "NCBIGENE"
      },
      "function": "Protein",
      "id": "702a6dc3cca8e92ccfd3c71c3000ba78"
    },
    {
      "bel": "path(CONSO:\"Clonal Expansion\")",
      "concept": {
        "name": "Clonal Expansion",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "817849adf69ce61fab2f8fede74fb9ea"
    },
    {
      "bel": "path(CONSO:Excitotoxicity)",
      "concept": {
        "name": "Excitotoxicity",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "3c37b0742431ce3c53b58624adcec97c"
    },
    {
      "bel": "path(MESH:\"Age of Onset\")",
      "concept": {
        "name": "Age of Onset",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "d706b8f839571f7a697849dd378d900b"
    },
    {
      "bel": "path(MESH:\"Antibody Formation\")",
      "concept": {
        "name": "Antibody Formation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "40e4b488962bceabfb85ed30456518e1"
    },
    {
      "bel": "path(MESH:\"Antigen Presentation\")",
      "concept": {
        "name": "Antigen Presentation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "a68850d020456470e01aca314b34b140"
    },
    {
      "bel": "path(MESH:\"Autoimmune Diseases\")",
      "concept": {
        "name": "Autoimmune Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0aeb632260f15842cdd2b5e3c4b15c15"
    },
    {
      "bel": "path(MESH:\"B-Lymphocytes\")",
      "concept": {
        "name": "B-Lymphocytes",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "38413039bf8352c30ce66dced77efc20"
    },
    {
      "bel": "path(MESH:\"Central Nervous System Diseases\")",
      "concept": {
        "name": "Central Nervous System Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "1114043399ecabdf9c223540cf1dade5"
    },
    {
      "bel": "path(MESH:\"Complement Activation\")",
      "concept": {
        "name": "Complement Activation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "6dda9b230c8390f4edaaac15ebcf89c5"
    },
    {
      "bel": "path(MESH:\"Demyelinating Diseases\")",
      "concept": {
        "name": "Demyelinating Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "fd58854d02026d9f5fa3d1ebdeaee004"
    },
    {
      "bel": "path(MESH:\"Developmental Disabilities\")",
      "concept": {
        "name": "Developmental Disabilities",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "afe60a3de79a9186b4f309de5217bf50"
    },
    {
      "bel": "path(MESH:\"Diffuse Axonal Injury\")",
      "concept": {
        "name": "Diffuse Axonal Injury",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "5c071ab33c311b21362da90fd43f77d1"
    },
    {
      "bel": "path(MESH:\"Disease Resistance\")",
      "concept": {
        "name": "Disease Resistance",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "b3d14e48a29bb8774cd91cfd6534b0e7"
    },
    {
      "bel": "path(MESH:\"Encephalomyelitis, Autoimmune, Experimental\")",
      "concept": {
        "name": "Encephalomyelitis, Autoimmune, Experimental",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e0e7d121b14480684b390d8b04193e91"
    },
    {
      "bel": "path(MESH:\"Energy Metabolism\")",
      "concept": {
        "name": "Energy Metabolism",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "266b2ade166522498effb10b3b6890c9"
    },
    {
      "bel": "path(MESH:\"Epstein-Barr Virus Infections\")",
      "concept": {
        "name": "Epstein-Barr Virus Infections",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "152f451c5e17ac13db8d9a8224992412"
    },
    {
      "bel": "path(MESH:\"Immunity, Humoral\")",
      "concept": {
        "name": "Immunity, Humoral",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "c43c9414b8166fb209d0acdc797f1379"
    },
    {
      "bel": "path(MESH:\"Leukemia, Promyelocytic, Acute\")",
      "concept": {
        "name": "Leukemia, Promyelocytic, Acute",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "766a60930bf36d8ab05eb94475616a0f"
    },
    {
      "bel": "path(MESH:\"Mitochondrial Diseases\")",
      "concept": {
        "name": "Mitochondrial Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "23abb882b2958f2aad620337f92d6e12"
    },
    {
      "bel": "path(MESH:\"Multiple Sclerosis\")",
      "concept": {
        "name": "Multiple Sclerosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "075dea8e440aa2624d0899dd5060868e"
    },
    {
      "bel": "path(MESH:\"Multiple Sclerosis, Chronic Progressive\")",
      "concept": {
        "name": "Multiple Sclerosis, Chronic Progressive",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "4dc05b53deadbb6dcd241b6d39f0f32a"
    },
    {
      "bel": "path(MESH:\"Multiple Sclerosis, Relapsing-Remitting\")",
      "concept": {
        "name": "Multiple Sclerosis, Relapsing-Remitting",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "1c041f3b0601eb83b8dfbcdcef015e03"
    },
    {
      "bel": "path(MESH:\"Nerve Degeneration\")",
      "concept": {
        "name": "Nerve Degeneration",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "bd71074b83821b058b5c279e57109ef0"
    },
    {
      "bel": "path(MESH:\"Neural Conduction\")",
      "concept": {
        "name": "Neural Conduction",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "d06c5ac8d440954755ef66c3774cc71d"
    },
    {
      "bel": "path(MESH:\"Neurodegenerative Diseases\")",
      "concept": {
        "name": "Neurodegenerative Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "c04acd23e7e69b92e4e4230d8551fcf4"
    },
    {
      "bel": "path(MESH:\"Neurologic Manifestations\")",
      "concept": {
        "name": "Neurologic Manifestations",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0bf18f7ddf2f4951a317157d5e47cd2d"
    },
    {
      "bel": "path(MESH:\"Optic Atrophy, Hereditary, Leber\")",
      "concept": {
        "name": "Optic Atrophy, Hereditary, Leber",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "8f615bf0665c6b47e7a369f98a34de28"
    },
    {
      "bel": "path(MESH:\"Oxidative Stress\")",
      "concept": {
        "name": "Oxidative Stress",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "5d5071d9dea362c9b9b6ee5de9eb67be"
    },
    {
      "bel": "path(MESH:\"Population Density\")",
      "concept": {
        "name": "Population Density",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "751f58179ce818b0bbf82472a8d7cba6"
    },
    {
      "bel": "path(MESH:\"Tertiary Lymphoid Structures\")",
      "concept": {
        "name": "Tertiary Lymphoid Structures",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "02ac2614e2ebcb7438b192cfc6bbf0ea"
    },
    {
      "bel": "path(MESH:\"Wounds and Injuries\")",
      "concept": {
        "name": "Wounds and Injuries",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "1b05ca7def743c6a806d2347dcc495d3"
    },
    {
      "bel": "path(MESH:Aging)",
      "concept": {
        "name": "Aging",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "b6a3eeccec3150857599adf152d20e7c"
    },
    {
      "bel": "path(MESH:Atrophy)",
      "concept": {
        "name": "Atrophy",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "7d5394b2784c6e661c25500d859dc266"
    },
    {
      "bel": "path(MESH:Autoimmunity)",
      "concept": {
        "name": "Autoimmunity",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2a0e48081887306f061cbcd497625105"
    },
    {
      "bel": "path(MESH:Cardiomyopathies)",
      "concept": {
        "name": "Cardiomyopathies",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "91057480e7ac135456dd2552d3634fa8"
    },
    {
      "bel": "path(MESH:Cytoskeleton)",
      "concept": {
        "name": "Cytoskeleton",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "78efc1a78042feed3f89357a91998378"
    },
    {
      "bel": "path(MESH:Disease)",
      "concept": {
        "name": "Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0c4021b2257b83799cf001fb0c2cf1ab"
    },
    {
      "bel": "path(MESH:Immunity)",
      "concept": {
        "name": "Immunity",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "424748a9a78045ed955401a3dcedc709"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    },
    {
      "bel": "path(MESH:Meningitis)",
      "concept": {
        "name": "Meningitis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "de1b8fae2c3475b6d223ff0982fea7bf"
    },
    {
      "bel": "path(MESH:Neuroprotection)",
      "concept": {
        "name": "Neuroprotection",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "7ef62c4ba407ffc14d70776ab6de3c1b"
    },
    {
      "bel": "path(MESH:Pathology)",
      "concept": {
        "name": "Pathology",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "30821842828eae02c6e953a34f0cbf29"
    },
    {
      "bel": "path(MESH:Phagocytosis)",
      "concept": {
        "name": "Phagocytosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0ee0b5d73bc76bf98bf2b62f26e072f4"
    },
    {
      "bel": "path(MESH:Remyelination)",
      "concept": {
        "name": "Remyelination",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "df8b527e62d05045914f189de5e5bdc2"
    }
  ]
}